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Membrane proteins sense extracellular cues and transduce intracellular signaling to 
coordinate directionality and speed during cellular migration. They are often localized to 
specific regions, as with lipid rafts or tetraspanin-enriched microdomains; however, the 
dynamic interactions of tetraspanins with diverse receptors within tetraspanin-enriched 
microdomains on cellular surfaces remain largely unexplored. Here, we investigated how 
Transmembrane 4 L six family member 5 (TM4SF5), a membrane protein, regulate 
directionality cell migration by extracellular environment like extracellular matrix (ECM) 
and cholesterol depletion, and by intracellular signaling like microtubule modification 
and dynamic interaction of protein partners.  
 Transmembrane 4 L six family member 5 (TM4SF5) translocates between endosomal 
and plasma membranes to promote cell migration, although the regulation of this 
trafficking remains unknown. Here, the roles of the extracellular environment and 
2 
 
intracellular signaling in this trafficking were examined. The persistent migration of 
TM4SF5-expressing cells was associated with greater enrichments of TM4SF5 at the 
leading edges. In comparison to poly-L-lysine, cell adhesion to fibronectin enhanced the 
velocity and straightness of the trafficking of TM4SF5-containing vesicles toward the 
plasma membrane. The facilitation of trafficking was associated with tubulin acetylation 
and more persistent and faster cell migration. Additionally, SLAC2B suppression reduced 
HDAC6 activity in cells plated on fibronectin, resulting in increased tubulin acetylation, 
enhanced vesicle trafficking, and persistent cell migration. Thus, the results of this study 
show that SLAC2B regulates microtubule acetylation via interaction with HDAC6, 
enabling the trafficking of TM4SF5-containing vesicles to the leading membranes to 
promote cell migration. 
 Here, we investigated effects of tetraspan(in) TM4SF5 (transmembrane 4 L6 family 
member 5)-enriched microdomains (T5ERMs) on the directionality of cell migration. 
Physical association of TM4SF5 with epidermal growth factor receptor (EGFR) and 
integrin a5 was visualized by live fluorescence cross-correlation spectroscopy and higher-
resolution microscopy at the leading edge of migratory cells, presumably forming 
TM4SF5-enriched microdomains. Whereas TM4SF5 and EGFR colocalized at the 
migrating leading region more than at the rear, TM4SF5 and integrin a5 colocalized 
evenly throughout cells. Cholesterol depletion and disruption in TM4SF5 post-
translational modifications, including N-glycosylation and palmitoylation, 
alteredTM4SF5 interactions and cellular localization, which led to less cellular migration 
speed and directionality in 2- or 3-dimensional conditions. TM4SF5 controlled 
directional cellmigration and invasion, and importantly, these TM4SF5 functions were 
dependent on cholesterol, TM4SF5 post-translational modifications, and EGFR and 
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integrina5 activity. Altogether, we showed that TM4SF5 dynamically interacted with 
EGFR and integrin a5 in migratory cells to control directionality and invasion. 
 Altogether, TM4SF5 containing endosome vesicles trafficked toward plasma membrane 
by depending on fibronectin it connected, it formed T5ERMs with EGFR and integrin α5 
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Tetraspanins are protein family consist of four transmembrane domains including a small 
outer loop (EC1), a larger outer loop (EC2), a small inner loop (IL) and short cytoplasmic tails. 
Tetraspanin has special structural specificities including conserved extracellular cysteine residues, 
and polar residues within transmembrane domains. This structural specificity should be known as 
tetraspanin (Fig 1. 1)[1, 2] 
 
 
Figure 1. 1. Five distinct and functionally important regions in tetraspanin proteins.  
Reprinted from Trends in Biochemical Sciences, Vol 28, Christopher S. Stipp, Tatiana V. 
Kolesnikova, Martin E. Hemler, Functional domains in tetraspanin proteins, Pages 106-112., 




The large extracellular loop (EC2 region) is subdivided into variable (yellow) and constant 
(light brown) regions, the small extracellular loop (EC1 region), transmembrane (TM) domains 
(brown), palmitoylation sites (green) and C-terminal tail (light green). Mean percentage identities 
between four representative tetraspanins, and identities with mean percentage between human 
and zebrafish orthologs are also shown. Transmembrane domains 1, 3, and 4 contain known 
functionality of polar amino acids (Asn, Glu, Gln). Almost all Tetrapanin also contains a 
membrane-proximal cysteine that suffers palmitoylation. In addition to those highlighted here, at 
least 18 other amino acids (which are in EC2) are also significantly preserved among all known 
tetraspanins (between 65 and 95 percent of amino acids). 
The Tetrapanin protein group includes 30 in mammals, 37 in drosophila, and 20 in 
Caenorhabditis elegans. Some individual tetraphanins are abundant in plasma and/or endosomal 
or lysosomal compartments of almost all animal cell types [1, 3-5]. Tetraspanin does not have 
only an essential role in mammalian fertilization, but has functions in the immune system, brain 
and tumors, regulate cell motility and/or morphology, fusion, signaling [6-10]. 
The most famous tetraspanin, CD151 modulates integrin-induced cell morphology, 
migration, signal transduction and adhesion strengthening. In contrast, most tetraspanin family 
members have so far had little functional information. However, conclusive genetic evidence for 
a particular Tetrapanin function has recently become apparent to some Tetrapanins in humans, 




Table 1. 1. Genetic analysis of tetraspanin functions.  
Reprinted by permission from Springer Nature: Nature Reviews Molecular Cell Biology, 




2. Tetraspanin web 
One of the most distinctive features of the Tetrapanin family is its ability to form side-to-side 
relationships with several partner proteins in a dynamic assembly and to form lateral associations 
described by the tetraspanin web[11]. The interaction of tetraspanins with their partner proteins 
is very specific. Although they vary depending on their avidity, stoichiometry and the cellular site 
of their initial associations. They are divided into two main classes: direct interaction and indirect 
interaction[12]. Direct, called close proximal interactions can occur during biosynthesis, show 
high stoichiometry, known for being variably retained in strong (1% NP-40 or 1% Triton X-100) 
or milder (digitonin or 1% Brij 96 or Brij 97) detergents and can be shown by chemical 
crosslinking. Examples include the interactions ofCD9 and CD81 with EWI2 and EWI-F, which 
are members of the immunoglobulin superfamily that contain a EWI amino-acid motif. In general, 
indirect interactions resulting from the tetraspanin-tetraspanin interaction are maintained with 
mild detergents (1% brij 96 or brij 97) and are reinforced by the presence of divalent cations (such 
as Ca2+ and Mg2+) are of undefined cellular site of initial association and might depend on 
tetraspanin palmitoylation.  
Homo- and heterodimerization. 
CD81 LEL crystals consist of homodimers[13, 14], which represented that 
homodimerization occurs through the LEL. Homodimer required the TM domains and 
maintained by hydrophobic interactions, and did not need palmitoylation[15]. In tetraspanin 
web, they formed homodimers that further assemble into tetramers and other higher-order 
structures[16]. However, tetraspanin also form heterodimers with their partners. 





Figure 1. 2. Extracellular, lateral and intracellular interactions in the tetraspanin web. 
Reprinted by permission from Springer Nature: Nature Reviews Immunology, The tetraspanin 
web modulates immune-signalling complexes, Shoshana Levy, Tsipi Shoham, COPYRIGHT 
2005. [18] 
Palmitoylation. 
S-palmitoylation can also be important to configure the integrated tetraspanin 
microdomain and to control the signal transmission as a result of attachment. As from the 
CD81, the Palmitoylation of Tetrapanin may be important in regulating intercellular 
interactions. Tetraspanins contain intracellular cysteine residues that were expected to be 




Tetraspanin proteins had ability to associate with different transmembrane receptors and 
themselves, forming a distinct class of membrane domains, it called tetraspanin-enriched 
microdomains (TEMs). The different interaction of molecules leads to the formation of 
distinct domains (figure 1. 3)[19]. 
 
Figure 1. 3.  Plasma membrane structure and membrane domains. 
Reprinted from Trends in Cell Biology, Vol 19, María Yáñez-Mó et al., Tetraspanin-enriched 
microdomains: a functional unit in cell plasma membranes, Pages 434-446., Copyright 2009, with 
permission from Elsevier. [19] 
Tetraspanins in TEM have interactions at three different levels: the primary interactions between 
tetraspanins and non tetraspanin partners, secondary interactions between tetraspanins[20]. And 
tertiary interactions occurred in tetraspanins and cytosolic signaling molecules [2, 19]. 
Tetraspanins interact with themselves, growth factor receptors, integrins, membrane bound 
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growth factors, immunoglobulin superfamily proteins or signaling enzymes. TEM can regulate 
many phisiological and pathological processes like Fertilization, cell adhesion, motility, tumor 






TM4SF5 is component of tetraspanin-enriched microdomains. 
TM4SF5 belongs to transmembrane 4 L six family together with TM4SF1 (L6, L6-Ag), 
TM4SF4 (IL-TIMP), TM4SF18 (L6D), TM4SF19, and TM4SF20[21]. The transmembrane 
4 L six family is very similar to genuine tetraspanins in terms of membrane topology with 
four transmembrane domains, and two extra cellular loops and long extracellular loop with 
two short cytosolic N- and C-terminal tails. Whereas genuine TM4SFs have a conserved 
region and a variable region, including a CCG motif and four conserved cysteine residues in 
the loops and long extracellular loop[22].  
 
Figure 1. 4. Blast alignment of the TM4SF members (A) and their phylogenetic tree (B).  
Reprinted from Elsevier Books, Vol 319, Jung Weon Lee, International Review of Cell and 
Molecular Biology, Chapter Four - Transmembrane 4 L Six Family Member 5 (TM4SF5)-
Mediated Epithelial–Mesenchymal Transition in Liver Diseases, Pages 141-163., Copyright 2015, 
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with permission from Elsevier. [23] 
TM4SF5-enriched microdomain (T5EM) 
Because a member of the transmembrane 4 L six family similar to genuine tetraspanins, 
TM4SF5 could form a T5EM with other protein partners. TM4SF5 was shown to interact 
with integrins α2β1[24] and integrin α5[25], epidermal growth factor(EGF) receptor(EGFR) 
[26], transforming growth factor b receptor(TGFβR)and CD151[27, 28]. Therefore, 
TM4SF5 can play an important role in various cellular functions by engaging in the T5EM. 
TM4SF5-MEDIATED METASTATIC POTENTIAL 
TM4SF5-Mediated Direct Migration  
TM4SF5 mediates EMT and migration and invasion [29, 30]. It is very much 
present in liver cell species and plays a role in abnormal cell proliferation and enhanced 
metastatic potential[31]. Because TM4SF5 has N- and C-cytosolic termini, it leads to 
interaction with certain intracellular molecules to mediate signaling pathways and 
promote tumor progress. TM4SF5 can bind to FAK[30] and c-Src family kinase[32]. 
Therefore, TM4SF5 can activate FAK signal activity to create an actin organization at 
the front edge of the migratory cell membrane. As a membrane protein, TM4SF5 
appears to engage and activate the FAK directly during cell adhesion. F1 lobe of the 
FAK-FERM domain can directly bind to intracellular loop (ICL) of TM4SF5. The F1 
lobe leads auto phosphorylation (pY397FAK) and activation (pY577FAK) upon cell 
adhesion[30]. Other research reported that the K38A mutation in the FAK-FERM F1 
lobe activates FAK and promotes cell motility[33]. The interaction between TM4SF5 
and FAK cause FAK activation and activity mediation at the forward edge of the mobile 
cell through composite formation, together with Arf2, N-WASP and Cortatin.  
The C-terminal tail of TM4SF5 directly binds to c-Src and can regulates c-Src 
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activity[32]. Because TM4SF5 has unique protein subunits in C-terminal tail, it interacts 
with c-Src regions rather than the SH2SH3 domain. In addition, the C-terminus of 
TM4SF5 binds inactive form (non-phosphorylated pY416 Src) or kinase-dead c-Src more 
efficiently than active or Y416-phosphorylated c-Src, although active c-Src can still 
bind TM4SF5[32]. The interaction between c-Src and TM4SF5 regulating c-Src activity 
requires EGFR phosphorylation at Y845 but not Y992 orY1173. It cause effective 
formation of invasive protrusions. Y845F EGFR transfection does not change c-Src 
activity but suppresses invasive extrusion formation in TM4SF5 WT (Wild-type) cells. 
These results suggest that a signaling complex from c-Src to EGFR for invasive 
protrusion formation[32].  
TM4SF5 can dynamically interact with other membrane proteins and can regulate 
membrane activities to form local protrusions or retractions. Presumably it depends on 
different microenvironment near the membrane boundaries[23]. 
Cross-talk between tetraspanins 
Tetraspanin, located in TEM, plays the role of adhesion, movement, and invasion 
through homophilic or heterophilic interactions between tetraspanins, integrins, and 
growth factor receptors[2]. TM4SF5 can form TEMs with other tetraspanins and 
TM4SF members to play critical roles in the regulation of metastatic potentials. 
TM4SF5 already known to interact with EGFR[30] and TGFβR[27], integrin α2β1[24], 
integrin α5[25]. In addition with tetraspanis, TM4SF5 was shown to bind tumorigenic 
CD151, but not tumor-suppressive CD63[28]. It suggests supporting roles for TM4SF5 
in tumor progression as a tetraspanin molecule at TM4SF5-enriched 






Figure 1. 5. A working model for cellular functions depending on EMT supported by 
TM4SF5 at TM4SF5-enriched microdomains. 
Reprinted from Elsevier Books, Vol 319, Jung Weon Lee, International Review of Cell and 
Molecular Biology, Chapter Four - Transmembrane 4 L Six Family Member 5 (TM4SF5)-
Mediated Epithelial–Mesenchymal Transition in Liver Diseases, Pages 141-163., Copyright 2015, 
with permission from Elsevier. [23] 
4. Vesicle trafficking 
Membrane vesicle trafficking involves movement of vesicle containing important signal 
molecules from its synthesis-packaging location in the Golgi apparatus to specific locations on 
the inside of the plasma membrane of the secretory cell. The membrane-bound micro-sized 
27 
 
vesicles termed membrane vesicles. In this process, 'packaged' cell products are released outside 
of the cell through the plasma membrane. This process to move macromolecules into or out of 
the cell is active transport. There are two types of vesicle transport, endocytosis and 
exocytosis[34]. Both processes are requiring energy. 
 Endocytosis 
Endocytosis divided two types, phagocytosis and pinocytosis depending on engulfing 
materials. It is the process of capturing material or particles outside the cell by absorbing it 
along with the cell membrane. The membrane folds onto the material and is completely 
enclosed by the plasma membrane. After the process, membrane-bound vesicle moves the 
substance into the cytosol. Cell engulf large particles by phagocytosis and internalize 
materials in fluid condition by pinocytosis[35]. 
Phagocytosis is process which occurs when cell eats solid material enclosed with plasma 
membrane, forming a phagocytic vesicle. 
Pinocytosis is process which occurs when cell engulfs plasma membrane folded vesicle 
inward to form a channel allowing dissolved substances.  
Exocytosis 
Exocytosis is the process of vesicles enclosed with plasma membrane and releasing 
inside component to the outside of the cell. Cell can occur exocytosis when it made a protein 
that had to be transported outside or get rid of waste product or toxin. Generally, newly 
synthesized membrane proteins and lipids are trafficked on the top plasma membrane by 
exocytosis. Analyses of exocytosis in cells with relatively large secretory organelles, 
revealed that exocytosis involves the formation of transient and reversible fusion pores that 
can go through cycles of rapid openings and closings[36].  
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SLAC2B and molecules to regulate the trafficking 
Various small vesicles that transport proteins go through endocytic and secretory 
pathways between organelles. Newly made proteins are made in the rough endoplasmic 
reticulum and internalized to the cell surface. The trafficking pathway process is tightly 
controlled by the Rab/Ypt family of proteins[37]. The small GTPases share a three-
dimensional fold that can combine various downstream effector proteins with the GTP 
combination. GTP hydrolysis reaction induce a conformation change in the GTPase 
unrecognizable to its effectors. In this process, small GTPase are localizing and activating 
the effectors that control a wide range of cellular process to vesicle trafficking[38]. Rab 
proteins are one of the super family of small GTPase. Rab proteins are known for role in 
vesicle translocation and docking at aiming fusion site. Rabs are involved in modulating the 
levels of neurotransmitter release in neuronal system to underlie learning and memory[39]. 
Many kind of Rab proteins regulate vesicle trafficking process in vesicle budding, vesicle 
uncoating, motility and fusion by GTPase switch and its circuitry. Specially, Rab27A is well-
studied that take high specificity in the attachment of motors to vesicles. The direction and 
efficiency of the vesicle delivery is partly adjusted by actin filament and microtubule, which 
facilitate local and long-distance vesicle transport[40]. Rab27a and Rab27b control different 
steps of the exosome secretion pathway, the two Rab27 isoforms have different roles in the 
exosomal pathway. Rab27a can interact with SLAC2B which expresses exosome. Silencing 
of slac2b significantly reduced exosome secretion[41]. Rab27A bind to the Slp homology 
domain of synaptotagmin-like proteins 1-4 and Slac2[42]. By using whole-exosome 
sequencing, germline mutation in slac2b implicates the Rab2B effector protein in inherited 




5. Post translational modifications of the cytoskeleton 
Cytoskeleton is important for maintaining internal organization, shape, motility and 
cytokinesis of eukaryotic cells by controlling a network complex of polymeric filaments. 
Cytoskeleton is consist of three part, actin filament, intermediate filament and microtubule. In 
here, microtubules are main point, which are the largest cytoskeletal components have and 
external diameter of 25 nm. Microtubules control differentiate processes involving intracellular 
rearrangements and changes in morphology in core components of centrosomes, the centrioles, 
in core structures of cilia and flagella, axonemes and also essential role in neurogenesis[44].  
All microtubules are assemble of α-tubulin and β-tubulin to form heterodimers. Soluble α-
tubulin–β-tubulin dimers polymerize into microtubules in the presence of GTP condition, 
microtubules are heterogeneous in length and highly dynamic situations. Also tubulins are highly 
conserved among eukaryotes species[44]. 
The post translational modifications (PTMs) in microtubules have crucial role of microtubule 
function. Several PTMs of microtubules are studied: phosphorylation, ubiquitylation, 
sumoylation and palmitoylation[45], well known for occurring other proteins and detyrosination, 
Δ2-tubulin generation, polyglutamylation, polyglycylation and acetylation which are influenced 
in microtubule function. 
Tubulin destyrosination and the generation of Δ2-tubulin 
The enzymatic addition of Tyr to α-tubulin was demonstrated to be reversible 
process[46]. Removing Tyr functional group actually start tyrosination-detyrosination cycle, 
whereas re-addition of Tyr serve to reverse of the correction and the return of the tubulin to 
the initial state. Detyrosinate state of tubulin was referred to as Glu-tubulin, C-terminal 
residue of tubulin becomes exposed after detyrosination[47]. Detyrosinated tubulin could be 




Acetylation of tubulin occurred in Lys40 on α-tubulin different from other modifications 
which occurred in C- terminal residue[49]. Recently, another acetylation site was reported, 
at Lys252 on β-tubulin, to take place preferentially on non-polymerized tubulin[50]. There 
are two acetylating enzyme of tubulin, histone deacetylase 6 (HDAC6)[51] and sirtuin 2 
(SIRT2)[52]. Despite the HDAC enzymes are highly homologous, only HDAC6 has 
deacetylation activity on α-tubulin.  
Several transacetylase were known for α-tubulin acetylation on Lys 40. ARD1-NAT1 
(arrest-defective 1-aminoterminal, α-amino, acetylatransferase 1) and the ELP complex were 
known for tubulin acetyl transferase[53]. ELP complex was necessary for acetylation of α-
tubulin at Lys40. General control of amino acid synthesis 5 (GCN5) was also known for 
increasing acetylation on Lys40 of α-tubulin. Α-tubulin N-acetyltransferase 1 (α-TAT1) was 
most-well known protein to occur acetylation on α-tubulin[54]. Free tubulin dimer was 
existed most non-acetylated status by HDAC6 and polymerized with acetylated status by α-
TAT1. Also β-tubulin acetylated enzyme on Lys252 was known for acetyltransferase 





Figure 1. 6. Tubulin PTMs and modifying enzymes. 
Reprinted by permission from Springer Nature: Nature Reviews Molecular Cell Biology, Post-
translational regulation of the microtubule cytoskeleton: mechanisms and functions, Carsten 




Inhibitors to target post translational modification of microtubule 
Many inhibitors are known for targeting post translational modification of microtubules 
and they are actually being used in the medical treatment. Nocodazole and vinblastine can 
bind to tubulin dimers preventing polymerization and promoting depolymerization[55]. 
Another inhibitors related to tubulin polymerization are colchicine and combretastatin A4 
(CA-4) can bind to colchicine binding site of β-tubulin, preventing tubulin dimer assembly. 
Those inhibitors prevent tubulin polymerization with microtubule elongation following 
GTP-dependent tubulin dimer addition[56, 57]. Inhibitors well known about tubulin 
depolymerization was paclitaxel and docetaxel, both bind and stabilize αβ-tubulin dimers, 
prevent depolymerization and affect microtubule dynamics. They are role for shortening of 
microtubules by αβ-tubulin dimer removal[58]. Acetylation of tubulin can inhibited by 
tubacin which inhibitor of HDAC6 increasing tubulin deacetylation and trichostatin A (TSA) 
which deacetylase inhibitor that increases microtubule acetylation. By blocking acetylation 










Fibronectin-mediated microtubule acetylation regulates 





Transmembrane 4 L six family member 5 (TM4SF5) translocates between endosomal and 
plasma membranes to promote cell migration, although the regulation of this trafficking 
remains unknown. Here, the roles of the extracellular environment and intracellular 
signaling in this trafficking were examined. The persistent migration of TM4SF5-
expressing cells was associated with greater enrichments of TM4SF5 at the leading edges. 
In comparison to poly-L-lysine, cell adhesion to fibronectin enhanced the velocity and 
straightness of the trafficking of TM4SF5-containing vesicles toward the plasma 
membrane. The facilitation of trafficking was associated with tubulin acetylation and 
more persistent and faster cell migration. Additionally, SLAC2B suppression reduced 
HDAC6 activity in cells plated on fibronectin, resulting in increased tubulin acetylation, 
enhanced vesicle trafficking, and persistent cell migration. Altogether, the results of this 
study show that SLAC2B regulates microtubule acetylation via interaction with HDAC6, 
enabling the trafficking of TM4SF5-containing vesicles to the leading membranes to 






Cell migration is a critical component of various homeostatic and pathological cellular 
processes, such as during development, organ fibrosis, and cancer metastasis [60], and is 
modulated by bidirectional communication between the cell and the ECM, soluble factors, and 
neighboring cells [61]. The proteins and receptors on the plasma membranes (PMs) are critical 
for this communication. Thus, the trafficking and stabilization of membrane proteins at the cell 
surface mediate cellular behaviors under pathological conditions, such as during the metastatic 
migration of cancer cells. 
 Transmembrane 4 L six family member 5 (TM4SF5) is an N-glycosylated membrane protein 
with four transmembrane domains that forms microdomains on cell surface [23], similar to those 
formed by tetraspanins. As a membrane protein in microdomains, TM4SF5 forms complexes with 
the EGF receptor and integrin α5 [62] and can also bind to CD63, a tetraspanin that traffics 
between the lysosomal membrane and the PM [28]. The formation of these complexes is regulated 
by the palmitoylation of TM4SF5 and tetraspanins [62], [63]. On the cell surface, TM4SF5 also 
interacts with cytosolic signaling molecules such as focal adhesion kinase (FAK) [30] and c-Src 
[32] to promote migration and invasion, respectively. Although the roles of TM4SF5 on the cell 
surface have been widely studied, the intracellular trafficking of TM4SF5, which presumably 
depends on cellular needs and functions, remains unexplored. 
 Vesicles containing de novo synthesized or recycled membrane proteins are trafficked 
throughout the cell via the dynamic microtubule and F-actin networks [64]. The dynamics and 
heterogeneity of microtubules are influenced by their composition of α- and β-tubulins, diverse 
microtubule-interacting proteins (MIPs), and tubulin post-translational modifications (PTMs) 
[65], such as the acetylation of the ε-amino group of K40 of α-tubulin by the tubulin 
acetyltransferase α-TAT1 [66], [67]. These modifications are reversed by deacetylase, such as 
sirtuin type 2 [68] and histone deacetylase 6 (HDAC6) [69]. Acetylated microtubules are more 
stable and resistant to cold, nocodazole, and colchicine treatment [70], [71], [72]. Although other 
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lysine residues are acetylated, K40 of α -tubulin is the predominant acetylation site [73], which 
reduces microtubule breakages and increases microtubule flexibility by weakening the lateral 
interactions between protofilaments [74]. Whether microtubule acetylation affects other functions, 
such as vesicle trafficking, or is regulated by extracellular cues, such as the ECM, is largely 
unknown. 
This study examined the influence of microtubule acetylation and the ECM on the 
translocation of TM4SF5 to the leading edges of migratory cells. We found that fibronectin-
mediated cell adhesion enhanced the acetylation of microtubule via actions of SLAC2B and 
HDAC6, which was associated with increased translocation of TM4SF5-containing vesicles to 







1. Cells  
SNU449 and Huh7 cells were obtained from the Korean Cell Bank (Seoul National 
University, Korea), and maintained in RPMI-1640 or DMEM (HyClone, Chicago, IL) with 10% 
FBS (GenDEPOT, Barker, TX) at 37°C and 5% CO2. SNU449 cells stably expressing control or 
HA-tagged TM4SF5 expression plasmids were established via retrovirus infection previously 
described [75]. To generate TM4SF5-expressing retroviruses, Phoenix packaging cells were 
plated at 1 × 106 cells/60-mm culture dish and transfected with the pBabe-HAII retroviral vector 
(empty or containing wild-type TM4SF5 [TM4SF5WT-HAII] or TM4SF5Pal- with Ala mutations 
at Cys 2, 6, 9, 75, 76, 80, 81, 85, 189 palmitoylation-residues [TM4SF5Pal--HAII]). Supernatants 
containing the retroviruses were applied to SNU449 cells. Twenty four hours after infection, the 
cells underwent selections with puromycin (6 mg/ml; Sigma, St. Louis, MO) for 3 days. The cells 
were then maintained in RPMI-1640 containing 10% FBS and 1% penicillin/streptomycin 
(GenDEPOT) at 37°C and 5% CO2. 
To generate SLAC2B-overexpressing Huh7 cells, Platinum A packaging cells were 
transfected with the pBabe-HAII-SLAC2B retrovirus system (Cell Biolabs, Inc. San Diego, CA). 
Twenty-four hours after infection, Huh7 cells underwent selection with puromycin (1.5 mg/ml) 
for 3 days. The cells were then maintained in DMEM containing 10% FBS and 1% 
penicillin/streptomycin at 37°C and 5% CO2.  
SLAC2B knockdown was established in SNU449 cells via lentivirus infection. HEK293T 
packaging cells (1 × 106 cells/60-mm culture dish) were transfected with pLKO.1 lentiviral 
vectors containing short hairpins for a nonspecific sequence (shNS), shSLAC2B#1 (AGT AGT 
CAG GTG CCA GAA GAT GGC TTA TC), shSLAC2B#2 (GAG AAG GAC AGG ATC AGC 
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AAA CTT CAG AA), shSLAC2B#3 (ACA GTG TTC TCC AGG AGA AGT CCT TCA GA), 
or shSLAC2B#4 (GCC TCT CAT CCA ATG AGA AGC CAT ACA GA). Supernatants 
containing these lentiviruses were applied to SNU449 cells, and selections with puromycin (6 
mg/ml) were performed as described above. 
2. Cell lysate preparation and Western blotting 
Whole cell lysates from subconfluent cells cultured in normal media containing 10% FBS and 
transiently transfected with plasmids for 48 h or stably transfected/infected with vectors were 
obtained with lysis buffer containing 1% Triton X-100, 150 mM NaCl, 20 mM HEPES (pH 7.4), 
2 mM MgCl2, 2 mM CaCl2, and protease and phosphatase inhibitor cocktails (GenDEPOT). 
Protein concentrations in the lysates were normalized according to results from a BCA assay kit 
(Thermo Fisher Scientific, Pittsburgh, PA) and subjected to SDS-PAGE and subsequent 
immunoblotting with primary antibodies against HA.11 (clone 16B12, mouse mAb IgG1; 
Covance, Princeton, NJ), HDAC6 (clone D2E5, rabbit mAb IgG; Cell Signaling Technology, 
Danvers, MA), a-tubulin (clone 11H10, rabbit mAb IgG), pY118paxillin (rabbit polyclonal; Cell 
Signaling Technology, Danvers, MA), paxillin (clone 177/Paxillin, mouse mAb IgG1; BD 
transduction laboratories, Franklin Lakes, NJ), b-actin (clone C4, mouse mAb IgG1), acetylated 
a-tubulin (clone 6-11B-1, mouse mAb IgGb2; Santa Cruz Biotechnology, Dallas, TX), and 
GAPDH (rabbit polyclonal IgG; Cusabio, Wuhan, China). 
3. RNAi transfection 
Cells were transfected with siRNAs for 48 hours using Lipofectamine RNAiMAX 
Transfection Reagent (Thermo Fisher Scientific) following the manufacturer’s instructions. The 
SLAC2B siRNA was purchased from Santa Cruz Biotechnology (catalog number: sc-96916) and 
Paxillin siRNA was purchased from Bioneer (Daejeon, Korea). The human paxillin siRNA 
sequence were as follows: paxillin RNAi(#1), 5’-CCCUGACGAAAGAGAAGCCUA-3’ and 5’-
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UAGGCUUCUCUUUCGUCAGGG-3’; paxillin RNAi(#2), 5’-
GUGUGGAGCCUUCUUUGGU-3’ and 5’-ACCAAAGAAGGCUCCACAC-3’; control RNAi, 
5’-ACUCUAUCUGCACGCUGACUU-3’ and 5’-AAGUCAGCGUGCAGAUAGAGU-3’ [76]. 
4. Co-immunoprecipitation 
Whole cell lysates from cells cultured on fibronectin (10 mg/ml; BD Biosciences, San Jose, 
CA) and lysed in buffer containing 1% Brij 97, 150 mM NaCl, 20 mM HEPES (pH 7.4), 2 mM 
MgCl2, 2 mM CaCl2, and protease and phosphatase inhibitor cocktails underwent 
immunoprecipitation with the anti-HA.11 antibody and protein G-agarose (GenDEPOT) 
overnight at 4°C. The immunoprecipitates were washed three times each with ice-cold lysis buffer 
and PBS and then boiled in 2× SDS-PAGE sample buffer for standard Western blotting. 
5. RT-PCR 
Total RNA was isolated using QIAzol reagent (Qiagen, Venlo, Netherlands), and 
complementary DNA (cDNA) was synthesized using the ReverTra Ace qPCR RT master mix 
(Toyobo, Osaka, Japan) according to the manufacturer’s instructions. RT-PCR with the cDNA 
was performed with DreamTaq Green PCR master mix (Thermo Fisher Scientific) and the 
following primers for human mRNAs: for EXPH5, SLAC2B(0), 5¢-
GCAGGCAGTCAGGAAGTAAA-3¢ (forward) and 5¢-TCACTTTCCACAGGGCTAATG-3¢ 
(reverse); SLAC2B(1), 5¢-CTCAGAGCAAGAGTGGGTTTAT-3¢ (forward) and 5¢-
GGATGAGAGGCAGGCTTATTT-3¢ (reverse); for ACTB, 5¢-
TGACGGGGTCACCCACACTGTGCCCATCTA-3¢ (forward) and 5¢-
CTAGAAGCATTTGCGGTGGACGACGGAGGG-3¢ (reverse); for ATAT1, 5¢-
GGCGAGAACTCTTCCAGTAT-3¢ (forward) and 5¢-TTGTTCACCTGTGGGACT-3¢ (reverse). 
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6. 2D cell tracking 
Cells (1.5 × 103 cells per well) were trypsinized and replated on cover glass precoated with 
fibronectin (10 mg/ml) in a 10-well Chamlide incubator system (Live Cell Instrument, Seoul, 
South Korea). Time-lapse images were collected with an IX81-ZDC microscope (Olympus) 
equipped with an UPLSAPO 10X2, NA0.4 Super Apochromatic objective (Olympus) and an 
environmental chamber that maintained conditions of 37°C with 5% CO2 and 95% air at a flow 
rate of 40–60 ml/min via a controller (CU-109; Live Cell Instrument). All images were captured 
with a Prime sCMOS Camera (4.2 megapixel, BAE CIS-2020F sCMOS; Photometrics) and 
analyzed with MetaMorph software (Molecular Devices LLC, San Jose, CA). Individual cells 
were tracked using the “Track object” function, and cell tracks were generated using MS Excel 
and overlaid on individual image frames from movies. To calculate the index of directionality 
(confinement ratio), the shortest linear distance between the start and end points of the migration 
path (“distance to origin” panel) was compared with the total track distance (sum of the distances 
between each time point) of the migratory cell. A high confinement ratio (0.7-1.0) indicates high 
directional migration.  
7. Live fluorescence imaging 
SNU449 cells were transfected with mCherry-tagged TM4SF5WT or TM4SF5Pal- by 
electroporation with the NEON electroporation system (Thermo Fisher Scientific) according to 
the manufacturer’s protocols. Twenty-four hours later, the cells were trypsinized and seeded at 2 
× 103 cells per well on cover glass precoated with fibronectin or collagen I (Corning, Corning, 
NY) in an 8-well chambered cover glass system (Nunc, Rochester, NY). The cells were incubated 
at 37°C and 5% CO2 overnight and placed on C2+ Confocal Microscope (Nikon) coupled to an 
Eclipse Ti2 inverted microscope frame (Nikon) with an environmental chamber that maintained 
conditions of 37°C with 5% CO2 and 95% air at a flow rate of 40–60 ml/min via a controller (CU-
109). Images were obtained every 30 min for 6 h using a CFI Apochromat LWD Lambda S 20XC 
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WI, NA0.95 objective (Nikon) with 405-nm and 561-nm lasers and a normal PMT (Nikon). The 
images were exported as a TIFF or AVI format for analysis with NIS software (Nikon). 
8. TM4SF5 vesicle tracking 
Stable expression of EGFP-a-tubulinWT or the EGFP-a-tubulinK40R deacetylation mutant in 
SNU449 cells was established by lentivirus infection. HEK293T packaging cells were plated at 1 
× 106 cells/60-mm tissue culture dish and transfected with L304-EGFP-a-tubulinWT or L304-
EGFP-a-tubulinK40R plasmids (Addgene #64060 or #64059, respectively; gifted by Weiping Han). 
Supernatants containing these lentiviruses were applied to SNU449 cells, and selections with 
puromycin (6 mg/ml) were initiated 24 h after infection as described above. 
 EGFP-a-tubulin-expressing SNU449 cells were then electroporated with mCherry-tagged 
TM4SF5WT or TM4SF5Pal- with the NEON electroporation system. After 24 h, the cells were 
trypsinized and replated at 2 × 103 cells per well on cover glass precoated with 10 mg/ml 
fibronectin or collagen I in 8-well chambered cover glass system and incubated at 37°C in 5% 
CO2 overnight on an LSM 780 multiphoton laser scanning confocal microscope (Carl Zeiss, 
Oberkochen, Germany) equipped with a water immersion objective (C-Apochromat 63´/1.20 W 
Korr M27; Carl Zeiss) and a GaAsP multichannel spectral detector (QUASAR; Carl Zeiss). EGFP 
was excited with the 488-nm laser and mCherry was excited with the 561-nm laser at a minimal 
total power for a sufficient signal to noise ratio. For both lasers, the confocal pinhole diameter 
was 70 mm for the detection of emission of signals, which were split by a dichroic mirror 
(488/561-nm beam splitter) and detected at 490-544 nm for EGFP and at 588-668 nm for 
mCherry. A total of 300 image frames collected at 780 ms per frame were exported as CZI live 
image files from Zen 2012 acquisition software for analysis with Imaris software (Bitplane, 
Concord, MA). “Spots” for mCherry signals had estimated x and y axes diameters of 0.400 mm 
and a z axis diameter of 0.800 mm and background subtraction was performed. Spots with an 
intensity of >3,090 were defined by “Classify spot,” and the “Tracking algorithm” was Brownian 
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motion; the maximum distance was 2.00 mm, maximum gap size was 0 mm, and the fill gap option 
was not used. The “Classify tracks” algorithm used a track length between 3 mm and 100 mm. 
Values for x and y track displacement, track straightness, mean track speed, track length, and track 
duration were exported from the vantage panel. 
9. Immunofluorescence 
Cells incubated for 12 h on cover glass precoated with fibronectin or PLL were treated for 4 
h with 4 mM tubacin (Sigma), an HDAC6 inhibitor, or DMSO (vehicle control). The cells were 
then fixed with 3.7% formaldehyde (Sigma) for 20 min at RT and permeabilized with 0.1% Triton 
X-100 in PBS for 15 min at RT. The cells were blocked with 1% BSA (Bovogen, Keilor East, 
Australia) and then incubated with primary antibodies against HA.11, a-tubulin (clone B-7, 
mouse mAb IgG2a), acetylated a-tubulin, HDAC6, and FLAG (clone M2, mouse mAb IgG; 
Novus Biologicals, Littleton, CO) and anti-mouse/rabbit IgG(H+L), Alexa Fluor 488 or 555 
(Thermo Fisher Scientific), and DyLight 405 donkey anti-goat IgG(H+L) (Jackson 
ImmunoResearch, West Grove, PA) secondary antibodies. The cover glass was then mounted with 
ProLong Gold antifade reagent (Invitrogen, Carlsbad, California). Immunofluorescent images 
were acquired at RT using a C2+ confocal microscope (Nikon) with a normal PMT (Nikon) and 
a CFI Apochromat Lambda S 60× NA1.49 oil immersion objective (Nikon) after excitation with 
405 nm, 488 nm, and 561 nm laser lines. NIS software (Nikon) was used to calculate areas with 
TM4SF5 as follows. The active total regions of interest (ROIs) were defined to reflect the DIC 
image of individual cells at 2.5-mm intervals, and ROI regions for the red channel were converted 
to binary values that were exported to Excel. 
10. HDAC6 activity assay 
Untreated cells and cells treated with 2 mM tubacin for 30 min at 37°C (positive control) were 
lysed in a buffer containing 1% Triton X-100, 150 mM NaCl, 20 mM HEPES (pH 7.4), 2 mM 
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MgCl2, 2 mM CaCl2, and protease and phosphatase inhibitor cocktails. Protein concentrations in 
the lysates were determined with a BCA assay kit for normalization. HDAC6 activity was 
assessed with a commercial HDAC6 fluorescence activity assay kit (BML-AK516-0001, ENZO 
Life Science, Farmingdale, NY) according to the manufacturer’s protocol. The samples were 
placed in a fluorimeter microplate reader, and emissions at 440-460 nm were detected after 
excitation at 350-380 nm (SpectraMax; Molecular Devices).  
11. Statistical analysis 
Data are expressed as means and SDs. Two-tailed unpaired Student’s t tests were used for all 
comparisons between two groups. Nonparametric Mann-Whitney tests were used where 
appropriate. Comparisons among multiple groups were analyzed using one-way ANOVAs 
followed by Tukey’s multiple comparison tests or two-way ANOVAs followed by Sidak’s 






Enhanced cell migration is associated with enrichment of TM4SF5 but not a 
palmitoylation-deficient TM4SF5 mutant at the leading edge 
As TM4SF5 is known to direct cellular migration [62], we investigated whether this involves 
the regulation of the intracellular trafficking of the protein. We documented the dynamic 
localization of TM4SF5 molecules during cell migration. mCherry-tagged wild-type TM4SF5 
(TM4SF5WT) was enriched at the leading edges of mobile cells, whereas an mCherry-tagged 
palmitoylation-deficient mutant TM4SF5 (TM4SF5Pal-, [62]) or mCherry mock-control was not 
(Fig 2. 1A). In addition, migration was more persistent in cells expressing TM4SF5WT than in 
control cells (Fig 2. 1B) and those expressing TM4SF5Pal- [62]. The mean migration velocity of 
TM4SF5WT-expressing cells was higher than that of control cells (Fig 2. 1C). At time point later 
than 3 h, the velocities of both groups were indistinguishable, presumably due to gradually-
increasing cell densities or in vitro culture conditions. The confinement ratios of migratory cells 
for estimating the persistency of migration were also greater in cells expressing TM4SF5WT that 
in control cells (Fig 2. 1D). The enrichment of TM4SF5WT- but not TM4SF5Pal- at the leading 
edges along with the more persistent cellular migration at higher velocities suggests that the 
surface expression of TM4SF5 influences cell migration and that the trafficking of TM4SF5 to 
the cell surface is affected by palmitoylation. 
To investigate this further, we tracked individual TM4SF5WT- and TM4SF5Pal--containing 
vesicles via time-lapse imaging with laser scanning confocal microscopy. The images (Fig 2. 1E, 
top) were processed to extract individual tracks of the trafficking vesicles (Fig 2. 1E, middle), for 
analyses of displacement along x and y axes and the straightness of the tracks with Imaris software 
(Fig 2. 1E, bottom). The tracks of TM4SF5WT-containing vesicles were longer (at x and y axes) 
and straighter than those of TM4SF5Pal--containing vesicles (Fig 2. 1E). The translocation of 
these vesicles to the PM was analyzed by quantifying the fluorescence within 2.5 μm of the PM 
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edge (i.e., PM proximal) and comparing with that from other cellular regions (i.e., PM distal) (Fig 
2. 2A). The levels of enrichment of HA-tagged TM4SF5WT- and TM4SF5Pal--containing 
vesicles at the PM proximal region were similar when cells were plated on 10 μg/ml fibronectin 
(Fig 2. 1F). However, when cells were plated on poly-L-lysine (PLL), the PM proximal 
localization of TM4SF5WT-containing but not TM4SF5Pal--containing vesicles decreased 
significantly (Fig 2. 1F). Moreover, quantitative analyses of vesicle movement during time-lapse 
imaging revealed greater enrichment of TM4SF5WT-containing vesicles in the PM at the leading 
edge than of vesicles containing TM4SF5Pal- (Fig 2. 2B and 1G).  
Fibronectin-mediated cell adhesion promotes enrichment of TM4SF5 at the leading edge 
As fibronectin increased the localization of TM4SF5WT at the PM in comparison to that with 
PLL, we next examined the surface enrichment of TM4SF5 in cells exposed to different 
extracellular environment. Cells were plated on 2, 10, or 30 mg/ml of fibronectin or 10 mg/ml 
collagen I. The tracks of TM4SF5WT-containing vesicles in cells reseeded on 10 mg/ml fibronectin 
showed the greatest displacement (visualized as more widely-upward or -downward reached 
curves in the 3D graphs at the right side of each panel) and were straightest (visualized as more 
reddish and less bluish curves in the 3D graphs), whereas the straightness of the tracks of 
TM4SF5pal--containing vesicles did not differ in cells plated on the different substrates (Fig 2. 3A). 
Further analyses with Imaris software revealed that TM4SF5WT-containing vesicles traveled 
shorter distances and for shorter durations when cells were on 10 mg/ml fibronectin than when on 
the other substrates, whereas this was observed in TM4SF5Pal--containing vesicles in cells plated 
on 2 mg/ml fibronectin (Fig 2. 3B). Furthermore, TM4SF5WT-containing vesicles in cells plated 
on 10 mg/ml fibronectin traveled more persistently at greater speeds, whereas TM4SF5Pal--
containing vesicles did so when the cells were on 2 mg/ml fibronectin (Fig 2. 3B). Thus, the 
trafficking of TM4SF5WT-containing vesicles was more efficient when the extracellular 
environment contained 10 mg/ml fibronectin, whereas cells expressing the palmitoylation-
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deficient mutant trafficked vesicles more efficiently when the environment contained a lower 
concentration (2 mg/ml) of fibronectin. 
We next assessed the influence of microtubule acetylation on vesicle trafficking. For this, the 
acetylation of a-tubulin was increased by treating the cells with tubacin, a selective and cell-
permeable HDAC6 inhibitor [69]. The enhanced translocation of TM4SF5WT to the PM in cells 
plated on 10 mg/ml fibronectin was insignificantly affected by tubacin treatment. However, 
tubacin treatment increased the translocation of TM4SF5WT to the PM in cells plated on PLL (Fig 
2. 3C, left 4 bars). By contrast, the enrichment of TM4SF5Pal--containing vesicles in the PM 
proximal region was not significantly altered by the substrate or tubacin treatment (Fig 2. 3C, 
right 4 bars). Notably, the PM proximal localization of TM4SF5Pal--containing vesicles was 
slightly (but insignificantly) lower on PLL than on fibronectin (Fig 2. 4). Altogether, these 
observations suggested that the trafficking of vesicles containing TM4SF5 is influenced by ECM 
properties and intracellular tubulin acetylation, with higher fibronectin concentrations, and 
tubulin acetylation favoring PM translocation in a palmitoylation-dependent manner. 
Extracellular fibronectin promotes persistent migration of TM4SF5-positive cells 
The migration of cells expressing TM4SF5WT- or TM4SF5Pal- plated on different amounts of 
fibronectin was examined. Although the migration of cells expressing the empty vector control 
did not differ between 2 and 10 mg/ml fibronectin, cells expressing TM4SF5WT migrated more 
aggressively on 10 mg/ml fibronectin, whereas those expressing TM4SF5Pal- did so on 2 mg/ml 
fibronectin (Fig 2. 4A and 2. 6). Velocity measurement at different time points (i.e., instantaneous 
velocities) during time-lapse imaging revealed that the migration of cells expressing TM4SF5WT 
during the first 5 h was affected by the fibronectin concentration; the velocities were significantly 
higher when the cells were plated on 10 mg/ml fibronectin than on 2 mg/ml fibronectin (Fig 2. 5B 
and C) and were higher than those of cells expressing TM4SF5Pal- or the control plasmid when 
plated on 10 mg/ml fibronectin (Fig 2. 5B and C). 
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The mean velocities of cells expressing TM4SF5WT- or TM4SF5Pal- were comparable and 
higher than that of control cells when plated on 2 mg/ml fibronectin; the confinement ratios of 
TM4SF5WT- and TM4SF5Pal--expressing cells were lower than that of control cells, but the 
difference was not significant (Fig 2. 5D, left parts of graphs). When plated on 2 mg/ml 
fibronectin, cells expressing TM4SF5WT had a lower mean velocity and higher confinement ratio 
than cells expressing TM4SF5Pal- but a higher mean velocity and higher confinement when plated 
on 10 mg/ml fibronectin (Fig 2. 5D, right parts of graphs). Thus, we conclude that the migration 
of cells expressing TM4SF5WT is more persistent in the presence of high fibronectin 
concentrations. 
Microtubule acetylation is required for the trafficking of vesicles containing 
TM4SF5WT 
As tubacin treatment to cells on PLL increased the enrichment of TM4SF5WT-containing 
vesicles at the PM (see Fig 2. 3C), we next examined whether the trafficking of TM4SF5-
containing vesicles was dependent on a-tubulin acetylation. For these experiments, the trafficking 
of vesicles in cells expressing an acetylation-deficient K40R a-tubulin mutant was examined. 
Immunostaining revealed that TM4SF5WT accumulated in patches in cells expressing the K40R 
mutant but not in those expressing the wild-type a-tubulin (Fig 2. 7A and B). Moreover, the 
trafficking displacement (distance) and velocity of TM4SF5WT-containing vesicles were 
significantly decreased in cells expressing the K40R a-tubulin mutant (Fig 2. 7C and D). However, 
acetylation levels of a-tubulin were not altered by changes in the expression levels (Fig 2. 4E) or 
by palmitoylation- or N-glycosylation-deficiency (Fig 2. 7F) of TM4SF5 expression levels (Fig 





TM4SF5 co-localizes with SLAC2B and HDAC6 at the PM 
A proteomic analysis to identify binding partners of TM4SF5 identified SLAC2B (also known 
as exophilin 5 [77]) (Table 2. 1), which is known to be involved in the trafficking of endosomal 
vesicles in keratinocytes [77, 78]. We performed a co immunoprecipitation experiment with 
TM4SF5 and confirmed that it immunoprecipitated with SLAC2B as well as with HDAC6 (Fig 
2. 8A). Endogenous SLAC2B was shown to be colocalized with exogenous TM4SF5-FLAG at 
the membrane boundaries (Fig 2. 8B). Furthermore, exogenous SLAC2B and endogenous 
HDAC6 colocalized at the protrusive edges of cells plated on 10 mg/ml fibronectin but not on 
PLL (Fig 2. 8C). Therefore, these observations suggest that the protein complex consisting of 
TM4SF5, SLAC2B, and HDAC6 can exert functional collaborations proximally to the plasma 
membranes. 
SLAC2B regulates HDAC6 activity to retain microtubule acetylation 
 Furthermore, knockdown of SLAC2B in hepatocytes increased a-tubulin acetylation 
(Fig 2. 9A and B). However, knockdown or overexpression of SLAC2B did not alter mRNA levels 
of ATAT1, which encodes a-tubulin N-acetyltransferase (Fig 2. 9C and D). When SLAC2B 
expression was suppressed, acetylated microtubules extended toward the PM boundary (Fig 2. 
9E). The activity of HDAC6 was decreased in cells with SLAC2B knockdown as well as those 
treated with tubacin (Fig 2. 9F). These data suggest that SLAC2B may inhibit HDAC6 activity, 
leading to enhanced acetylation of a-tubulin that facilitates the trafficking of TM4SF5-containing 
vesicles to the PM. 
We also examined whether the enhanced a-tubulin acetylation resulting from the knockdown 
of SLAC2B occurred in an ECM-dependent manner. Cells with SLAC2B knockdown and control 
cells were reseeded on cover glass precoated with fibronectin (2 or 10 mg/ml) or collagen I (10 
mg/ml). Immunoblotting of the cell lysates revealed that SLAC2B suppression increased a-
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tubulin acetylation and concomitantly reduced HDAC6 activity in cells plated on 10 mg/ml 
fibronectin but not in those plated on collagen I or 2 mg/ml fibronectin (Fig 2. 9G and H). Further, 
the microtubule acetylation enhanced by SLAC2B suppression was dependent of paxillin 
expression (Fig 2. 9I), suggesting a linkage of cell adhesion (-related signaling pathway) to 
SLAC2B-mediated regulation of microtubule acetylation. These results suggest that SLAC2B in 
cells under a proper ECM environment regulates the activity of HDAC6 to modulate the level of 
a-tubulin acetylation and the growth of microtubules toward the PM. 
SLAC2B suppression leads to TM4SF5 enrichment at the PM and persistent cell 
migration 
We next investigated whether the SLAC2B-mediated regulation of microtubule acetylation 
led to persistent cell migration via an enrichment of TM4SF5WT-containing vesicles at the PM. 
The migration of cells expressing shSLAC2B (#1 or #3) or a shNS control and plated on 10 mg/ml 
fibronectin or non-precoated cover-glass was analyzed. SLAC2B-suppressed cells plated on 
fibronectin, but not those plated on non-precoated cover-glass, showed more aggressive migration, 
than the control cells (Fig 2. 10A), suggesting that SLAC2B-suppressed cells were more sensitive 
to the ECM environment with regard to migratory behaviors. Furthermore, the speed and mean 
velocity of cells with SLAC2B knockdown were higher than those of the control cells when plated 
on fibronectin (Fig 2. 10B and C, respectively) but not when plated on cover-glass without any 
precoating (Fig 2. 10D, E, and F). 
Moreover, TM4SF5WT-containing vesicles in cells with SLAC2B knockdown trafficked for 
shorter durations and distances at higher velocities than those in control cells (Fig 2. 10G, left 
three bars in each graph), resulting in a greater number of vesicles at the PM proximal region (Fig 
2. 10H). Interestingly, the trafficking distance and speed of TM4SF5Pal--containing vesicles were 
not different from those of TM4SF5WT-containing vesicles; however, the difference in 
confinement ratios and mean velocities of TM4SF5Pal--containing vesicles in control and 
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SLAC2B-suppressed cells was less than that observed between TM4SF5WT-containing vesicles 
(Fig 2. 10G, right three bars in each graph). The enrichments of TM4SF5WT- and TM4SF5Pal--
containing vesicles at the PM were similar in SLAC2B-suppressed cells (Fig 2. 10H and 11). 
These results suggest that SLAC2B restricts ECM-mediated migration by reducing the trafficking 









Figure. 2. 1. Persistent migration via enrichment of TM4SF5WT-containing vesicles at the 
leading edge of the PM. (A) Time-lapse (6 h) laser scanning confocal imaging of cells expressing 
plated on fibronectin (10 mg/ml) expressing control (mCherry) or mCherry-tagged TM4SF5WT or 
TM4SF5Pal-. Dotted circles indicate the cell boundaries at the starting time point. (B) Tracking of 
the migration of control or TM4SF5WT-expressing cells for 16 h by time-lapse microscopy. (C) 
Instantaneous velocities (mm/s) of individual cells during the first 4 h of live-cell imaging 
calculated with MetaMorph software. (D) Confinement ratio values of the individual cells tracked 
for 16 h were calculated with MetaMorph software. Values are means ± SDs. (E) Live-cell 
imaging of cells plated on fibronectin (10 mg/ml) co-expressing pEGFP-a-tubulin and TM4SF5WT 
or TM4SF5Pal-. The tracks of the TM4SF5-containing vesicles were extracted and analyzed for 
displacements in x and y axes and straightness. (F) Cells expressing TM4SF5WT-HA or 
TM4SF5Pal--HA and plated on fibronectin or PLL (10 mg/ml) were stained for DAPI (nuclei, blue) 
or the HA tag (red). The boundaries of the cells (white lines) were drawn manually, and 2.5-mm 
ROIs (between green and white lines) from the cell boundary were drawn as in Figure 2. 2A. 
Intensities of red fluorescence within the PM proximal and PM distal region were then measured 
(mean ± SD). (G) TM4SF5 localization at the front PM regions of a migratory cell were 
determined as in Figure 2. 2B after determining the migratory direction. ROI1 is the total PM 
proximal region and ROI2 is front half of the PM proximal regions perpendicular to the direction 
of migration. *p < 0.05, **p < 0.01, and ***p < 0.001 by two-way ANOVA with Sidak’s multiple 







Figure 2. 2. 
 
Figure 2. 2. Enrichment of TM4SF5WT-containing but not TM4SF5Pal--containing vesicles at 
the leading edge of the PM. (A) Cells expressing TM4SF5WT-HA or TM4SF5Pal--HA and plated 
on fibronectin or PLL (10 mg/ml) were stained for DAPI (nuclei, blue) or the HA tag (red). The 
boundaries of the cells (white lines) were drawn manually, and 2.5-mm ROIs (between green and 
white lines) from the cell boundary were drawn. Intensities of red fluorescence within the PM 
proximal and PM distal region were then measured. (B) TM4SF5 localization at the front PM 
regions of a migratory cell were determined as in panel A after determining the migratory 
direction. ROI1 is the total PM proximal region and ROI2 is front half of the PM proximal regions 









Figure 2. 3. Fibronectin-mediated cell adhesion promotes enrichment of TM4SF5 at the 
leading edge. Cells expressing TM4SF5WT-HA or TM4SF5Pal--HA on fibronectin (2, 10, or 30 
mg/ml) or collagen I (10 mg/ml) were imaged by laser confocal microscopy. (A) The tracks of 
trafficking vesicles were extracted (left parts of each panel) and analyzed in 3D graphic 
presentations (right graphs). (B) The displacement (distance in mm), duration (time in sec), 
straightness (directionality as a confinement ratio), and mean velocity (in mm/s) of the trafficking 
vesicles containing TM4SF5WT- (WT) or TM4SF5Pal- (Pal-). The red (for WT) and blue (for Pal-) 
curves for duration and mean velocity depict only the different trends of their mean values in each 
experimental condition without meanings in y axis values. (C) The localization TM4SF5WT-HA 
or TM4SF5Pal--HA proximal or distal to the PM was analyzed, as described in the legend for 
Figure 1F and 2A. *p < 0.05, **p < 0.01, and ***p < 0.001 by two-way ANOVA with Sidak’s 
multiple comparison test in panel B or one-way ANOVA with Tukey’s multiple comparison test 




Figure 2. 4.  
 
 
Figure 2. 4. Fibronectin-mediated cell adhesion promotes enrichment of TM4SF5WT-
containing but not TM4SF5Pal--containing vesicles at the leading edge of the PM. Cells 
expressing TM4SF5WT-HA or TM4SF5Pal--HA and plated on fibronectin or PLL (10 mg/ml) were 
stained for the HA tag (red). The boundaries of the cells (red lines) were drawn manually, and 
2.5-mm ROIs (between red and green lines) from the cell boundary were drawn. Intensities of red 












Figure 2. 5. Persistent migration of cells expressing TM4SF5 in the presence of high 
extracellular concentrations of fibronectin. (A) Individual cell tracking was performed via live 
imaging (12 h) of cells expressing empty vector control, TM4SF5WT-HA, or TM4SF5Pal--HA after 
plating on fibronectin (2 or 10 mg/ml). (B and C) Velocities (mm/s) of individual cells at each time 
point were analyzed and graphed (top graphs for 12 h and bottom graphs for the first 5 h). (D) 
Mean velocities (mm/s, top 2 graphs) or confinement ratios (for persistency in migration, bottom 
2 graphs) of cells for 12 h or the first 5 h were analyzed. Values are presented as means ± SDs. *p 
< 0.1, **p < 0.05, and ***p < 0.01 by nonparametric Mann-Whitney test; ns, not significant. Data 
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Figure 2. 6. Persistent migration of TM4SF5WT-expressing but not TM4SF5Pal--expressing 
cells on fibronectin substrate. Time-lapse (6 h) laser scanning confocal imaging of cells 
expressing control (mCherry) or mCherry-tagged TM4SF5WT or TM4SF5Pal- plated on fibronectin 
(2, 10, or 30 mg/ml) or collagen I (10 mg/ml). Dotted regions indicate the cell boundaries at the 









Figure 2. 7. Microtubule acetylation was involved in the TM4SF5WT-vesicle traffic. (A) Cells 
were transiently transfected with TM4SF5WT-HA (red) and either EGFP-tagged wild-type a-
tubulin WT or a K40R mutant (green) for 48 h, before live-imaging and then processing to indirect 
immunofluorescence. (B) Western blotting results for the indicated molecules of whole cell 
extracts. (C and D) Analysis of intracellular trafficking of TM4SF5WT-containing vesicles in cells 
expressing WT or K40R mutant a-tubulin as assessed by displacement (distance in mm) and mean 
velocity (mm/s). ***p < 0.001 by one-way ANOVA with Tukey’s multiple comparison test; ns, 
not significant. (E to G) Hepatocytes (HepG2 and Huh7) stably-infected with lentivirus for either 
control sequences (shNS) or shTM4SF5 (#2 or #4 sequences) and TM4SF5-null SNU449 
hepatocytes stably-infected with lentivirus for vectors containing various forms of TM4SF5 (WT 
or palmitoylation-deficient [Pal-] or N-glycosylation-deficient [Gly-] mutants) were harvested, 
and whole cell extracts were used for standard immunoblots for the indicated molecules (E and 
F). (G) Cells stably-infected with lentivirus for control or TM4SF5-specific shRNAs and plated 
on fibronectin (10 mg/ml) were immunostained for a-tubulin or acetylated-a-tubulin (Ac-a-
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Figure 2. 8. TM4SF5 co-localizes with SLAC2B and HDAC6 at the PM. (A) 
Immunoprecipitation with an HA tag antibody was performed with extracts of Huh7 cells stably-
infected with retrovirus for either control or HAII-SLAC2B plasmids. The immunoprecipitates 
were then used for immunoblotting with antibodies against TM4SF5, HA, and HDAC6. (B) 
SNU449 cells (in A) transfected with TM4SF5-FLAG for 48 h were processed for 
immunostaining using normal IgG (as a control) or anti-SLAC2B (green) or anti-FLAG tag (red) 
antibody, before capturing images with a confocal microscopy. (C) Huh7 cells stably-infected 
with retrovirus for pBABE-HA control or HAII-SLAC2B and plated on fibronectin or PLL were 
stained for DAPI (nuclei, blue) and immunostained for the HA tag (green) and HDAC6 (red). 
Data represent three isolated experiments. 
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Figure 2. 9. SLAC2B regulates HDAC6 activity for microtubule acetylation. (A to C) 
Hepatocytes were transfected with siRNAs for 48 h (A) or stably-infected with lentivirus for 
shRNA against a control sequence (NS) or SLAC2B (#1, #2, #3, and #4 sequence of SLAC2B). 
The cells were then analyzed by RT-PCR (A, B, and C) and Western blotting (A and B). (D) Huh7 
cells were stably-infected with retrovirus for control (empty vector) or HAII-SLAC2B and 
analyzed by RT-PCR. (E and F) SNU449 cells stably-infected with lentivirus for either control 
(shNS) or shSLAC2B (#1 or #3) and plated on 10 mg/ml fibronectin were immunostained for Ac-
a-tubulin. (E) On the phase contrast images, the cellular boundaries (yellow lines) were drawn 
manually to clarify the distribution of Ac-a-tubulin at the PM region. (F) HDAC6 activity was 
measured in whole cell extracts from these cells; cells treated with tubacin served as a positive 
control. (G and H) Hepatocytes stably-infected with lentivirus for shNS or shSLAC2B and plated 
on fibronectin (FN, 2 or 10 mg/ml) or PLL (10 mg/ml) were processed for standard 
immunoblotting for the indicated molecules (G) or for the HDAC6 assay (H). Values are presented 
as means ± SDs. *p < 0.05, **p < 0.01, and ***p < 0.001 by nonparametric Mann-Whitney test; 
ns, not significant (H). (I) Hepatocytes stably-infected with lentivirus for shNS or shSLAC2B 
plated on fibronectin (10 mg/ml) were transfected with siRNA for control or paxillin sequences 
(#1 and #2) for 48 h, before whole cell lysate preparation and immunoblottings. Data represent 









Figure 2. 10. SLAC2B suppression promotes cell migration and enriches TM4SF5 at the PM. 
(A to F) The migration of cells stably-infected with lentivirus for either shNS (control) or 
shSLAC2B (#1 or #3) and plated on 10 mg/ml fibronectin (A, B, and C) or non-precoated cover-
glass (D, E, and F) was tracked for 12 h. (B and E) Velocities (mm/s) of individual cells at different 
time points were measured (left graph for 12 h and right graph for the first 5 h, B). (C and F) 
Mean velocities (mm/s, left graphs) or confinement ratios (for persistency in migration, right 
graphs) of cells for the first 5 h (C) or over 12 h (C and F) were calculated; values are the means 
± SDs. *p < 0.05, **p < 0.01, and ***p < 0.001 by nonparametric Mann-Whitney test; ns, not 
significant. (G and H) Vesicles in cells expressing TM4SF5WT-HA or TM4SF5Pal--HA and either 
shNS or shSLAC2B (#1 or #3) and plated on fibronectin (10 mg/ml) were tracked, and the 
displacement (mm), duration (sec), straightness (confinement ratio), and mean velocity (mm/s) 
were measured. Values are presented as means ± SDs. *p < 0.05, **p < 0.01, and ***p < 0.001 
by two-way ANOVA with Sidak’s multiple comparison tests; ns, not significant (G). (H) 
Localization of vesicles containing TM4SF5WT-HA or TM4SF5Pal--HA at the PM were analyzed 
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Figure 2. 11. SLAC2B suppression-mediated microtubule acetylation for enrichment of 
TM4SF5-containing vesicles at the PM. Cells were prepared to stably express shRNA for a 
control or SLAC2B sequences (#1 or #3). The cells further expressing TM4SF5WT-FLAG or 
TM4SF5Pal--FLAG and plated on fibronectin (10 mg/ml) were stained for DNA with DAPI 
(Nuclei, blue) or for the FLAG tag (red). The boundaries of the cells (red lines) were drawn 
manually, and 2.5-mm ROIs (between white and green lines) from the cell boundary were drawn. 
Intensities of red fluorescence within the PM proximal and PM distal region were then measured. 
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highly similar to 
Calnexin 
IPI00020984 
(+1) 72 kDa 12 14 - - 
annexin A4 IPI00793199 36 kDa 5 6 - - 
Claudin-1 IPI00000691 (+1) 23 kDa 2 1 - - 
Isoform 2 of 
Exophilin-5 
(SLAC2B) 
IPI00168769-R 222 kDa 2 1 - - 
Golgin subfamily 
B member 1 
IPI00004671-R 
(+2) 372 kDa 0 2 - - 
 
Table 2. 1. List of proteins linked to vesicle secretion among TM4SF5 binding partners in 
liver cancer cells by mass spectrometry. SNU761 hepatic carcinoma cells were transfected with 
control or Strep-tag-conjugated TM4SF5WT plasmid for 48 h, and then harvested using 1% Brij58 
lysis buffer. Lysates were immunoprecipitated using streptavidin agarose (Thermo Fisher 
Scientific, Pittsburgh, PA) and samples were loaded in SDS-PAGE gel. After in-gel trypsin 
digestion of proteins, peptides were analyzed in LC-MS/MS. The amino acid sequence can be 
deduced after searches in the NCBI data using the program SEQUEST. Data was organized by 
Human IPI database (Ver. 3.82) and analyzed by SCAFFOLD 3 analysis and the experiments 






The results from this study show that the ECM influences the trafficking of TM4SF5 to the 
PM at the leading edge of migrating cells. This process is facilitated by TM4SF5 palmitoylation 
and microtubule acetylation modulated by the SLAC2B-involved regulation of HDAC6. 
Specifically, we found that the enrichment of TM4SF5 at the PM corresponded to enhanced cell 
migration, an effect that was lost in cells expressing a palmitoylation-deficient TM4SF5 mutant. 
The trafficking of TM4SF5 and subsequent cell migration were facilitated by high concentrations 
of fibronectin in the extracellular environment. The enrichment of TM4SF5 at the leading edge 
relied on the acetylation of K40 of a-tubulin, which was regulated by an intracellular signaling 
pathway including SLAC2B and HDAC6, which are both binding partners of TM4SF5. 
TM4SF5 may traffic between endosomal membranes and PMs in a manner similar to that of 
CD63 between lysosomal membranes and PMs on the basis of the physiological needs of the cell 
[28]. Indeed, we found that TM4SF5 localizes to the endosome (lysosome) during mTORC1 
activation upon amino acid repletion (JWJ and JWL, unpublished observations). TM4SF5-
enriched microdomains formed at the PM via protein-protein interactions with other tetraspanins, 
integrins such as integrin a5, and receptors for growth factors such as EGF[62], [23], as observed 
at the leading edge of migrating cells, can activate focal adhesion kinase and actin polymerization 
to promote directional migration[30]. The results presented here clarify the mechanism by which 
the ECM facilitates the intracellular trafficking of TM4SF5 leading to enhanced migration. 
Tetraspanins, including TM4SF5, can regulate the trafficking or stability of their binding 
partners, membrane proteins and receptors [77-79]. Palmitoylation deficiency impairs tetraspanin 
interactions [79] and the binding of TM4SF5 to its partners [62], which include cytosolic proteins 
such as focal adhesion kinase [30], c-Src [32], and SLAC2B, as shown here. Presumably, the lack 
of sensitivity to the ECM and microtubule acetylation observed with the palmitoylation-deficient 
TM4SF5 mutant in this study was a result of impaired interactions with these binding partners 
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and presumably others, leading to its accumulation in abnormal patches around the PM. 
 Notably, vesicular trafficking in and the migration of cells expressing a palmitoylation-
deficient TM4SF5 mutant were impaired. However, the enrichment of vesicles containing the 
mutant at the PM was similar to that for vesicles containing the WT protein. A reason for this 
discrepancy may be that TM4SF5Pal--containing vesicles were trafficked to the PM irrespective 
of the migratory direction due to the loss of protein interactions underlying ECM sensitivity and 
microtubule acetylation. For example, TM4SF5Pal--containing vesicles might not be able to form 
protein-protein complexes within the trafficking machinery necessary for the directional delivery 
of the vesicles. 
This study reveals that HDAC6 regulation of a-tubulin acetylation, which facilitates the 
trafficking of TM4SF5 to the PM, is affected by the concentration and type of proteins comprising 
the ECM in the extracellular environment. Cell adhesion with specific ECM components may 
trigger downstream signaling to regulate tubulin acetylation. Paxillin, an adaptor protein at focal 
adhesions involving integrin receptors and the ECM, directly binds and partially inhibits HDAC6 
for microtubule acetylation-dependent cell polarization and migration, and HDAC6 inhibition 
restores motility in paxillin-depleted cells [80]. Indeed, here SLAC2B suppression-mediated α-
tubulin acetylation could be blocked by paxillin suppression. Accordingly, the results from this 
study showed that SLAC2B also plays a role in the ECM-mediated regulation of HDAC6 activity 
for microtubule acetylation, which may involve the formation of a complex with paxillin and 
TM4SF5. 
In summary, the findings from this study provide evidence that extracellular ECM- and 
SLAC2B/HDAC6-mediated microtubule acetylation facilitates the trafficking of TM4SF5, but 
not a palmitoylation-deficient mutant, to the PM at the leading edge of a migrating cell. This in 











Dynamic and coordinated single-molecular interactions at 
TM4SF5-enriched microdomains guide invasive behaviors in 













Membrane proteins sense extracellular cues and transduce intracellular signaling to coordinate 
directionalityand speed during cellular migration. They are often localized to specific regions, as 
with lipid rafts ortetraspanin-enriched microdomains; however, the dynamic interactions of 
tetraspanins with diverse receptors within tetraspanin-enriched microdomains on cellular surfaces 
remain largely unexplored. Here, we investigated effects of tetraspan(in)TM4SF5 
(transmembrane 4 L six familymember 5)-enriched microdomains (T5ERMs) on the 
directionality of cell migration. Physical association of TM4SF5 with epidermal growth factor 
receptor (EGFR) and integrin a5 was visualized by live fluorescence cross-correlation 
spectroscopy and higher-resolution microscopy at the leading edge of migratory cells, presumably 
forming TM4SF5-enriched microdomains. Whereas TM4SF5 and EGFR colocalized at the 
migrating leading region more than at the rear, TM4SF5 and integrin a5 colocalized evenly 
throughout cells. Cholesterol depletion and disruption in TM4SF5 post-translational 
modifications, including N-glycosylation and palmitoylation, alteredTM4SF5 interactions and 
cellular localization, which led to less cellular migration speed and directionality in 2- or 3-
dimensional conditions. TM4SF5 controlled directional cell migration and invasion, and 
importantly, these TM4SF5 functions were dependent on cholesterol, TM4SF5 post-translational 
modifications, and EGFR and integrina5 activity. Altogether, we showed that TM4SF5 







Tetraspanins, or the transmembrane 4 superfamily (TM4SF), are a group of membrane 
proteins that collaborate with integrins for cell adhesion and migration [8, 20]. TM4SF members 
interact with themselves, growth factor receptors, Ig superfamily proteins, signaling enzymes, and 
integrins, presumably at tetraspanin-enriched microdomains (TERMs) [2]. TERMs are organized 
membrane structures that regulate many physiologic and pathologic processes, including 
adhesion, motility, and invasion [81]. Therefore, the dynamic protein associations in a TERM can 
finely tune the spatiotemporal signaling activity of a migratory cell and coordinate the diverse 
biologic processes that underlie migration directionality. However, coordinated intra-TERM 
protein dynamics that steer migration directionality remain unexplored in live cells. 
Transmembrane 4 L6 family member 5 (TM4SF5) is highly expressed in different cancers and is 
a membrane glycoprotein with 4 transmembrane domains [82]. TM4SF5 also has 4 
transmembrane domains: a short and a long extracellular loop (LEL), an intracellular loop (ICL), 
and cytosolic N and C termini. TM4SF5 differs from TM4SFs with respect to CCG motifs and 
sequence variations in the LEL [83]. LEL of TM4SF5 contains the N-glycosylation sites N138 
and N155 [84]. ICL of TM4SF5 interacts with focal adhesion kinase (FAK), which leads to a 
signaling link of TM4SF5/FAK to actin organization machinery upon integrin binding to the 
extracellular matrix (ECM) during migration [30]. The C terminus of TM4SF5 binds c-Src to 
form invasive protrusions during invasion [32]. In zebrafish, tm4sf5 knockdown disturbs the 
localization of integrin α5 and disrupts localization of extracellular fibronectin and intracellular 
FAK, vinculin, and actin at the somite boundaries—and all of these effects are abolished by the 
concomitant introduction of zebrafish tm4sf5 cDNA [85]. Thus, the role of TM4SF5 in 
developmental regulation during somite and myotome formation may be via its interaction with 
FAK [30] and/or integrins [85]. TM4SF5 has been hypothesized to form TM4SF5-enriched 
microdomains (T5ERMs) via interactions of TM4SF5 with integrins or growth factor receptors 
[84]; however, intra-T5ERM spatiotemporal protein interactions that are essential for cell 
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migration and invasion remain unclear. 
In this study, we explored the dynamic spatiotemporal associations of TM4SF5 with integrin 
α5 and epidermal growth factor receptor (EGFR) in live migratory cells. By using 2-dimensional 
(2D) and 3-dimensional (3D) collagen gel systems, we showed that TM4SF5 associated with 
EGFR and integrin α5 at the leading cell edges to coordinate cell migration velocity and 
directionality. Of importance, we further showed that these interactions, localizations, and 
functions of TM4SF5 were dependent on TM4SF5 post-translational modifications (PTMs), 
including N-glycosylation and/or palmitoylation, cellular cholesterol levels, and EGFR and 






1. Cells.  
Human SNU761 and SNU449 hepatocytes and HEK293Tembryonic kidney cells were 
obtained from the Korean CellBank (Seoul National University, Seoul, South Korea). Cells were 
stably infected with pBabe-HAII alone, as a mock control, or with pBabe-HAII retrovirus coding 
for wild-typeTM4SF5 (TM4SF5WT), TM4SF5NQNA (N-glycosylation-deficientTM4SF5 with 
N138Q/N158A double mutations), TM4SF5Pal-(palmitoylation-deficient TM4SF5 with 
mutations of cysteine residues 2, 6, 9, 74, 75, 79, 80, 84, 189 to alanines), or other cysteine 
mutants. After infection, cells were incubated for 3dandselectedby using 2 mg/ml puromycin 
(Sigma-Aldrich, St. Louis, MO,USA) for an additional 24 h. SNU761 cells that express mock 
ordiverseTM4SF5 forms have been previously described [32]. Cells were maintained in RPMI-
1640 (WelGene, Daegu, South Korea) that contained 10% fetal bovine serum (FBS; GenDepot, 
Barker, TX,USA) and1%penicillin/streptomycin (GenDepot) at 37°C in5% CO2. Cells were 
checked for mycoplasma every other month and their identities were confirmed upon purchase 
from the Korean Cell Bank. 
2. Plasmid DNA and transfection. 
Wild-type human TM4SF5 (NM-003963, TM4SF5WT) insert was cloned into the 
mammalian expression vector pEXPR-IBA 103(IBA, Olivette, MO, USA) or retroviral 
expression vector pBabe-HAII. TM4SF5NQNA and TM4SF5Pal- were engineered by using the 
QuikChange Site-Directed Mutagenesis Kit (Stratagene, LaJolla,CA,USA), and their sequences 
were confirmed. Other point mutations at the cytosolic cysteines of TM4SF5were generated in 
the same manner. TM4SF5WT and TM4SF5Pal- were also cloned into pmCherry-C1 and 
confirmed by sequence analyses. Human integrin a5-green fluorescent protein (GFP) and EGFR-
GFP were purchased from Addgene (Cambridge, MA, USA). Transient expression of 
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TM4SF5WT or mutant plasmids was achieved via transfection with Lipofectamine 3000 Reagent 
(Thermo Fisher Scientific, Waltham, MA, USA) or by using electroporation with the Neon 
Electroporation System (Thermo Fisher Scientific)according to manufacturer protocol. 
3. Cell lysate preparation and Western blots. 
 Sub confluent cells that were grown in normal culture medium were transiently 
transfected with plasmids for 48 h or stably infected with retroviruses. These were then harvested 
for whole-cell lysate preparation using a lysis buffer that contained1% Brij58 (or Brij97 or Triton 
X-100), 150 mM NaCl,20 mM HEPES, pH 7.4, 2 mM MgCl2, 2 mMCaCl2, and protease and 
phosphatase inhibitor cocktails (GenDepot).SNU761 cells treated with vehicle or MbCD (10 mM) 
for 1 h were fractionated using the Proteo Extract Subcellular Proteome Extraction Calbiochem 
Kit (Merck Millipore, Darmstadt, Germany) before immunoblotting. Alternatively, cells were 
kept in suspension or reseeded onto fibronectin (FN;10mg/ml;BDBiosciences, San 
Jose,CA,USA)-precoated culture dishes for 90 min [30] and, as indicated, were treated with 
EGF(100 ng/ml) for the last 10 min of culture. Lysates were normalized and immunoblotted by 
using the following primary Abs: fibroblast growth factor receptor 2, pY861FAK, pSer/Thr 
(Abcam, Cambridge, United Kingdom), integrin a5,pY397FAK, FAK, pTyr (BD Transduction 
Laboratory, Bedford, MA, USA), pY845EGFR, pY1068EGFR, pY1173EGFR, Flag,pY416c-
Src, CD9, paxillin, pY118paxillin (Cell Signaling Technology, Danvers, MA, USA), 
HA.11(16B12) (Covance, Princeton, NJ, USA), StrepMAB-Classic conjugated to 
horseradishperoxidase (IBA), cortactin (Merck Millipore), EGFR,CD63, b-actin, caveolin-1, c-
Src (Santa Cruz Biotechnology,Santa Cruz, CA, USA), and pY577FAK (Thermo 
FisherScientific). 
4. Sucrose-gradient fractionation. 
Cells (2 3 107 cells/condition) with or without methyl-b-cyclodextrin (MbCD) 




5. Coimmunoprecipitation.  
Whole-cell lysates were precipitated with Pierce High-Capacity Streptavidin Agarose 
(Thermo Fisher Scientific) overnight at 4°C. Precipitates were washed 3 times with lysis buffer, 
3 times with ice-cold PBS, and then boiled in 23 SDS-PAGE sample buffer before 
immunoblotting. 
6. Palmitoylation analysis.  
Palmitoylation of TM4SF5WT and mutants was analyzed as described previously [87]. In 
brief, cells were washed with PBS and labeled overnight with [9,10-3H]palmitic acid 
(PerkinElmer, Waltham, MA, USA) in DMEM (or L-15 medium) without FBS. Cells were then 
incubated with 10% FBS-containing medium for 24 hand harvested by using lysis buffer with 
0.1% SDS and 1% NP-40.Insoluble material was pelleted at 12,000 g for 30 min, and cell lysates 
were incubated for 12 h at 4°C with streptavidin agarose resin (Thermo Fisher Scientific). After 
5 successive washes with precipitation buffer and PBS, protein precipitates were eluted from 
beads with Laemmli sample buffer, and proteins were resolved by SDS-PAGE. Gels were treated 
with Amplify Enhancing Reagent (Amersham Biosciences, Little Chalfont, United Kingdom) 
according to manufacturer protocol. Gels were then dried and exposed to X-ray Kodak film for 
30 d at 280°C (Kodak, Rochester, NY, USA) 
7. Proximity ligation assays.  
 Duolink In Situ Orange Starter Kit (Sigma-Aldrich) was used for this assay. Culture 
inserts (Ibidi, Martinsried, Germany) were attached to FN-pre coated glass-bottom dishes (SPL 
LifeScience, Pocheonsi, South Korea) before cells were reseeded.SNU761 cells that stably 
expressed Flag-tagged TM4SF5wereseeded to obtain confluency on either side of the chamber. 
Oneday later, culture inserts were removed and cells moved toward the middle of the empty space 
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for 24 h. Cells were then fixed and permeabilized for immunofluorescence. After 
permeabilization,cells were incubated in the kit-supplied blocking buffer overnight at 37°C in a 
humidified chamber. The following day, cells were incubated with primary Abs diluted in Ab 
diluents overnight at 4°C. Cells were then washed 3 times for15 min each in kit-supplied buffer 
A and incubated with kit supplied proximity ligation assay (PLA) probes for 1hat 
37°Cinahumidified chamber. This incubation was followed by successive10- and 5-min washes 
in buffer A. Ligation reaction was carried out at 37°C for 1 h in a humidified chamber, followed 
by successive10- and 5-min washes in buffer A. Cells were then incubated with kit-supplied 
amplification mix for 2 h at 37°C in a humidified chamber, followed by successive 10- and 1-
minwashes with 13and 0.013dilutions, respectively, of kit-supplied buffer B. Finally, cells were 
mounted by using the mounting media supplied with the kit and were imaged using confocal 
microscopy (Nikon, Tokyo, Japan). After PLA, immunofluorescence using anti-Flag Ab was 
further processed. Images were analyzed by using Imaris imaging software (Bitplane AG, Zurich, 
Switzerland). 
8. 2D cell tracking.  
Cells were trypsinized and replated on FN (10 mg/ml)-precoated cover glass in a 10-well 
Chamlide Incubator System (Live Cell Instrument,Seoul, South Korea) at 1 3 103 cells/well. 
Time-lapse images were collected for the indicated periods by using an IX81-ZDCmicroscope 
(Olympus, Tokyo, Japan) with an environmental chamber maintained at constant conditions of 
37°C, 5% CO2, and 95% humidity. All images were captured and analyzed with MetaMorph 
Software (Sunnyvale, CA, USA) to track individual cells and to determine their index of 
directionality (the shortest linear distance between the start point and the endpoint of a migration 
path divided by the total track distance of the cell). A higher index of directionality (0.7–1.0) 
indicates highly directional migration. 
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9. Indirect immunofluorescence. 
Cells were seeded on glass coverslips that were precoated with FN (10 mg/ml). After 12 h, 
MbCD (10 mM; Sigma-Aldrich) or vehicle was added to serum-free RPMI-1640 culture media 
for1 h. Cells were then processed for indirect immunofluorescence, as previously described [28], 
with the following primary Abs:Flag (Novus Biologicals, Littleton, CO, USA), Alexa Fluor 488–
conjugated Flag (Cell Signaling Technology), EGFR (ThermoFisher Scientific), pY397FAK 
(Abcam), caveolin-1 (Santa CruzBiotechnology), and integrin a5 (P1D6 or SNAKA51; 
MerckMillipore). Immunofluorescent images were acquired at 37°C by using a confocal 
microscope with a Nikon Plan-Apochromat360/1.4 N.A. oil objective (Nikon eclipse Ti) or a 
fluorescent microscope (BX51TR; Olympus). Confocal images were analyzed by using NIS 
software (Nikon) to obtain Mander’s overlapcoefficients (MOCs). 
10. Florescence cross-correlation spectroscopy. 
Florescence cross-correlation spectroscopy (FCCS) measurements were all performed at 
25°C with an LSM780 confocal microscope (Carl Zeiss, Oberkochen, Germany) as described 
previously [88]. Fluorescence correlation spectroscopy and FCCS setups using the LSM780 
microscope consisted of a continuous-wave Ar+ laser (25 mW) and a solid-state laser(20mW), a 
water-immersion objective (C-Apochromat,340/1.2NA; Carl Zeiss), and 2 channels of a GaAsP 
multichannel spectral detector (Quasar; Carl Zeiss). GFP was excited with the488-nm laser line 
and red fluorescent proteins (i.e., mCherry) with the 561-nmlaser line, with a minimal total power 
to allow an optimal signal-to-noise ratio. Confocal pinhole diameter was adjusted to 37 mm for 
the 488 and 561 nm lasers. Emission signals were split by a dichroic mirror (488/561 nm beam 
splitter) and detected at 500–550 nm in the green channel for GFP and at 600–690 nm in the red 
channel for mCherry. Fluorescence correlation spectroscopy and FCCS data were analyzed with 
analytical software installed in the ZEN 2012acquisition software (Carl Zeiss). In brief, the 
fluorescence autocorrelation functions (FAFs) of the red and green channels, Gr (τ) and Gg (τ), 
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and the fluorescence cross-correlation function, Gc (τ), were calculated from: 
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where τ denotes the time delay, Ii the fluorescence intensity of the red channel (i=r) or green 
channel (i=g), and Gr (τ), Gg (τ) and Gc (τ) denote the fluorescence auto-correlation functions 
(FAFs) of red (i=j=x=r), green (i=j=x=g), and fluorescence cross (i=r, j=g, x=r) correlation 
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Where Fi and τι are the fraction and diffusion time of component i respectively. N is the 
average number of fluorescent particles in the excitation-detection volume defined by the radius 
w0 and the length 2z0, and s is the structure parameter representing the ratio s=z0/w0.  The 
structure parameter was calibrated using Rhodamine-6G (Rh6G) standard solution at 25 °C. 
Positions of FCCS measurement were selected at the plasma membrane of cell bottom. All Gx(t) 
in live cells were sequentially measured six times for 10s at one position. For FCCS measurement 
of mCherry tagged protein, there was rapid photo bleach at the beginning of first measurement 
and then average fluorescence became static from second measurement. Such rapidly photo 
bleached data were discarded from analysis. The data containing large single fluctuation of 
fluorescence intensity occasionally detected by slowly moving fluorescent vesicle were also 
discarded from analysis. All measured FAFs from live cells were globally fitted by the software 
(ZEN) installed on LSM780 system using the two-component model (i = 2) with or without triplet 
term to estimate the diffusion coefficient.[88]  For simplicity, triplet term in Eq. (2) was not 
shown. For FCCS analysis, the amplitude of the cross-correlation function was normalized to the 
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amplitude of the autocorrelation function of GFP or mCherry to calculate the relative cross-
correlation amplitude ([Gc(0)-1]/[Gr(0)-1]) corresponding to the fraction of associated molecules 
(Nc/Ng). As negative control, FCCS measurement was performed using the cells co-expressing 
GFP and mCherry. No positive cross-correlation signal was observed even at a high expression 
level . (Fig 3. 7B) 
11. Super-resolution microscopy. 
SNU761 cells were transiently transfected with TM4SF5WTmCherryor TM4SF5Pal--
mCherry and EGFR-GFP or integrina5-GFP for 48 h. Time-lapse fluorescence microscopy videos 
were taken with or without MbCD (10mM) treatment with an inverted, confocal, laser scanning 
microscope (LSM880 confocal microscope; Carl Zeiss) equipped with an Airyscansuper-
resolution imaging module and a 363/1.40 NA Plan-Apochromat Oil Differential Interference 
Contrast M27objective lens (Carl Zeiss). LSM observations were all performed at room 
temperature. EGFP was detected by excitation at 488 nm by using an argon laser (0.3% laser 
output)with a 495- to 550-nm band-pass filter, and mCherry was detected by excitation at 561 nm 
by using a Diode-Pumped Solid-State laser (0.3% laser output) with 570-nm long-passfilter. 
Microscopy images and videos were processed and analyzed by using Zen 2012 software. Videos 
were filmed at8 frames/s. 
12. Live imaging of spheroids in 3D collagen I gels. 
Cells were cultured for spheroid formation by using Perfecta3D96-well hanging-drop plates 
(3D Biomatrix, Ann Arbor,MI, USA) for 48 h. Spheroids were collected and embedded into 3D 
collagen I gels (2 mg/ml; BD Biosciences) in the presence or absence of MbCD (4 mM), the 
specific inhibitor of EGFR kinase inhibitor gefitinib (1 mM), the specific FAK inhibitorPF271 
[or PF-562271, 1 mM (8)], or the functional neutralizing anti-human integrin a5mAb (clone P1D6, 
20 mg/ml; Merck Millipore) in RPMI-1640 medium with 10% FBS. Time-lapse images were 
saved by using an IX81-ZDC microscope(Olympus). Spheroids were immunostained as 
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previously described [89]. 
13. RT-PCR. 
Total RNA was isolated by using Qiazol reagent (Qiagen, Venlo, TheNetherlands), and cDNA 
was synthesized by using the amfi-Rivert Platinum cDNA Synthesis Master Mix (GenDepot) 
according to manufacturer instructions. cDNA was subjected to PCR with Dream Taq Green PCR 
Master Mix (Thermo Fisher Scientific). Primers were as follows: human TM4SF5: forward, 59–
CTGCCTCGTCTGCATTGTGG–39; reverse, 59–CAGAAGACACCAATGGTCGCG–39; and 
human b-actin: forward, 59–TGACGGGGTCACCCACACTGTGCCCATCTA–39; reverse, 59–
CTAGAAGCATTTGCGGTGGACGACGGAGGG–39. 
14. Proteomic analysis for TM4SF5-binding proteins. 
SNU761 cells were ectopically transfected with control or Strep tag–conjugated TM4SF5WT 
plasmid for 48 h, and then extracted using a lysis buffer with mild detergent Brij58. Lysates were 
immunoprecipitated using streptavidin-agarose. After in-gel trypsin digestion of proteins, 
peptides were analyzed in LC-MS/MS. The amino acid sequence can be deduced after searches 
in the National Center for Biotechnology Information (Bethesda, MD, USA) data using the 
Sequest program (Sorcerer 2; Sage-N research,Inc., Milpitas, CA, USA). Data was obtained from 
the Human IPI database (ver. 3.82; www.ebi.ac.uk) and analyzed by Scaffold 3 (Proteome 
Software, Portland, OR, USA). The experiments were performed twice. 
15. Statistical methods. 
Student’s t tests or 1-way ANOVA were performed for comparison of mean values to 





Colocalization of TM4SF5, EGFR, and integrin α5 at the leading edge of migratory 
cells. 
Proteomic analysis was performed in duplicate to identify TM4SF5 binding partners, 
especially membrane proteins (Table 3. 1), by using SNU761 hepatocytes that stably expressed 
Strep-tag–conjugated TM4SF5 (TM4SF5-Strep) compared with control. To confirm the 
associations of some of the identified binders, we performed coimmunoprecipitation and found 
that EGFR and integrin α5 bound to TM4SF5, whereas fibroblast growth factor receptor 2 and 
tetraspanin CD63 did not (Fig 3. 1A). Strep-tagged TM4SF5 showed multiple bands (Fig 3. 1A), 
likely because TM4SF5 is N-glycosylated and has been shown to multimerize even in SDS-
containing lysis buffer [24]. To assess the colocalization of TM4SF5, EGFR, and integrin α5 
during migration, we performed cell wounding assay. After cell wounding, all 3 proteins 
colocalized at the leading edges of cells migrating into the wound (Fig 3. 1B), which indicated 
that their colocalization is involved in migration directionality. To determine the extent of 
colocalization, we performed PLA to detect an association between TM4SF5-Flag (green; Fig 3. 
1C) and EGFR or integrin α5 (red dots; Fig 3. 1C). Along the leading membrane edges, there 
were a certain population of molecules colocalized (yellow; Fig 3. 1C), which further 
demonstrated an association between TM4SF5 and EGFR and/or integrin α5 at the leading edges 
of migrating cells. 
PTM-dependent TM4SF5 localization at lipid raft–like TERM fractions.  
To determine the role of PTMs in TM4SF5 localization, we generated PTM-deficient TM4SF5 
mutants. First, we immunoblotted TM4SF5-Strep precipitates by using anti–phospho-Tyr or anti–
phospho-Ser/Thr Abs and failed to detect any signal, which suggested that TM4SF5 is not 
phosphorylated (Fig 3. 2A). Next, we generated palmitoylation-deficient TM4SF5 by mutating 
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cytosolic cysteines, which are conserved among transmembrane 4 L6 family members, to alanines 
(Fig 3. 2B–3. 3C). To determine whether these mutations affected palmitoylation, we labeled 
TM4SF5WT, and each mutant with [3H]-palmitate (Fig 3. 3B). Immunoblotting showed that 
cysteine residues in the N or C terminus alone were not required, whereas those within the ICL 
were required, at least in part, for TM4SF5 palmitoylation. Moreover, mutations of all 9 cysteines 
[C2/6/9/74/75/79/80/84/189A (Pal−); mutant referred to as TM4SF5Pal-] almost completely 
abolished TM4SF5 palmitoylation (Fig 3. 2C and 3. 3C). We also used an N-glycosylation–
deficient TM4SF5 mutant, TM4SF5NQNA [24, 30]. 
 Next, we fractionated extracts from cells that expressed TM4SF5WT, TM4SF5Pal-, or 
TM4SF5NQNA by using sucrose-gradient analysis. TM4SF5WT fractionated into lipid raft–like 
and non–raft-like fractions, whereas both PTM mutants only fractionated into non–raft-like 
fractions (Fig 3. 3D). Furthermore, TM4SF5NQNA mutant was observed largely in an aggregated 
form, often remaining in the stacking gel during electrophoresis, unlike TM4SF5WT or 
TM4SF5Pal- (Fig 3. 3D). We also showed that TM4SF5WT and TM4SF5Pal- were localized to 
plasma membranes and intracellular endosomes, whereas TM4SF5NQNA was not detectable at 
plasma membranes (Fig 3. 3E). We next separated cell extracts into cytosol (C), membrane (M; 
plasma membrane and endosomal membranes), nuclear (N), and insoluble cytoskeletal protein-
associated (Ck) fractions. TM4SF5WT and TM4SF5Pal- were found in the M and Ck fractions, as 
were EGFR and integrin α5, whereas the monomer and multimeric forms of TM4SF5NQNA were 
found mostly in Ck fractions, and, to a lesser extent, in the M fraction (Fig 3. 1D). Of interest, Ck 
fractions of TM4SF5WT, EGFR, integrin α5, and tetraspanin CD9 were decreased by MβCD 
treatment to deplete cellular cholesterol (Fig 3. 1D). 
Because protein interactions at TERMs are dependent on detergents [2], we tested whether the 
interactions would be altered upon protein extraction by using the nonionic detergent Brij58 (Figs. 
3. 1A and 3. 2E) or Brij97 (Fig 3. 1F). The association between TM4SF5 and tetraspanin CD9 
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was confirmed; however, this association required a certain level of palmitoylation of TM4SF5 
(Fig 3. 1F). We also found that TM4SF5NQNA mutant did not bind to EGFR and integrin α5 (Fig 
3. 1E), likely because the mutant did not localize to the plasma membranes (Fig 3. 3E) and/or 
lacked N-glycosylation. However, TM4SF5Pal- mutant showed unchanged or slightly enhanced 
binding to EGFR but decreased binding to integrin α5 compared with that of TM4SF5WT (Fig 3. 
1F). Upon MβCD treatment, TM4SF5WT similarly showed slightly enhanced binding to EGFR 
but less to integrin α5, whereas TM4SF5Pal- showed slightly increased binding to EGFR and 
integrin α5 (Fig 3. 1F). TM4SF5ICL-Pal− mutant with approximately 50% palmitoylation level, 
compared with that of WT (Fig 3. 3C), showed greater binding to EGFR and unchanged binding 
to integrin α5 (Fig 3. 1F). 
Dynamic alteration in the TM4SF5 complex upon cholesterol depletion. 
To test whether T5ERM might be different from lipid rafts, we have checked the 
fractionations of TM4SF5 by using different lysis buffers that contained either Triton X-100 or 
Brij97, because lipid rafts are typically disrupted in nonionic detergents, but TERMs are mostly 
stable in nonionic detergents [2]. Although sucrose-gradient fractionation using Triton X-100–
containing buffer revealed the presence of TM4SF5WT in lipid raft–like and non–raft-like 
fractions (Fig 3. 3D and Fig 3. 4A), Brij97-detergent fractionation of SNU761-TM4SF5WT cells 
showed that TM4SF5WT fractionated into a fraction slightly lighter than that of caveolin-1, which 
suggested that T5ERMs are uniquely different from lipid rafts (Fig 3. 4A, B). Furthermore, small 
populations of EGFR, integrin α5, and c-Src were found in this fraction (Fig 3. 4A). In breast 
cancer MDA-MB-231 cells, all 3 of these molecules fractionated in raft-like T5ERM fractions 
(data not shown). Upon MβCD treatment of TM4SF5WT cells, caveolin-1 translocated from the 
lipid raft to the non–lipid raft fraction, whereas TM4SF5WT seemed to be enriched in the lipid 
raft–like T5ERM fraction (Fig 3. 4C). The differential fractionation of TM4SF5 from the 
caveolin-1 fraction using Brij97 detergent or MβCD treatment suggests that T5ERM is not 
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dependent on caveolin-1 and that T5ERMs are distinct domains from lipid rafts or caveolae. 
Treatment of control SNU761-Mock and SNU761-TM4SF5WT cells with MβCD resulted 
in a shrunken cell phenotype, with loss of cell-cell contacts and enriched cortical F-actin, in both 
groups (Fig 3. 4D). Moreover, costaining of TM4SF5WT and a lysozyme tracker showed that 
TM4SF5WT translocated to an area distal to the membrane boundaries, hereafter referred to as 
internal T5ERM, after MβCD treatment (Fig 3. 4D). Histograms for TM4SF5WT and lysozyme 
tracker staining were separate from one another (Fig 3. 5), which suggested that internal T5ERM 
are at plasma membranes but not endosomal membranes. 
 MβCD treatment also caused cells to round up and detach, and decreased pY397FAK-
positive focal adhesions independent of TM4SF5 expression (Fig 3. 4E). In vehicle-treated cells, 
TM4SF5 colocalized with EGFR and integrin α5 in areas at cell edges, hereafter referred to as 
boundary T5ERM (Fig 3. 4E, white arrowheads). In MβCD-treated cells, TM4SF5WT 
colocalized with EGFR at the internal T5ERMs (Fig 3. 4E, sky blue asterisks), but integrin α5 
remained at membrane boundaries (Fig 3. 4E, red arrowheads). MβCD treatment decreased 
caveolin-1 and c-Src levels in lipid raft–like fractions independent of TM4SF5 expression and 
abolished TM4SF5WT-enhanced pY416c-Src levels, whereas TM4SF5, EGFR, and integrin α5 
levels were maintained in lipid raft–like T5ERM fractions (data not shown). These observations 
indicated that TM4SF5 and its interacting partners differentially localize to the boundary or 
internal T5ERMs, respectively, without or with treatment of MβCD to deplete cholesterol. 
Next, we further investigated the effects of MβCD treatment on the interactions among 
TM4SF5, EGFR, and integrin α5. After MβCD treatment, SNU761-Mock cells showed increased 
colocalization of EGFR and integrin α5 at an area distal to the plasma membrane boundary (Fig 
3. 4F, upper right panels, outlined areas), whereas SNU761-TM4SF5WT cells showed enhanced 
colocalization of EGFR and TM4SF5 at internal T5ERMs compared with TM4SF5 and integrin 
α5 (Fig 3. 4F, middle right panels, outlined areas, and Fig 3. 5). After MβCD treatment, SNU761- 
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TM4SF5Pal- cells showed increased colocalization of EGFR and integrin α5, similar to that 
observed in SNU761-Mock cells (Fig 3. 4F, yellow regions within areas c and d). Vehicle-treated 
SNU761-TM4SF5WT cells showed abundant colocalization of TM4SF5, EGFR, and integrin α5 
along plasma membrane edges, whereas MβCD-treated SNU761-TM4SF5WT cells showed 
dramatic colocalization of TM4SF5 and EGFR at internal T5ERMs, with significant levels of 
integrin α5 alone at the boundary (Fig 3. 4G, a, b), as shown in Figs 3. 4E and 3. 4F. Of interest, 
TM4SF5Pal- cells showed very little integrin α5 at membrane boundaries even after MβCD 
treatment, and they showed slightly increased colocalization of TM4SF5 and EGFR at internal 
T5ERMs (Fig 3. 4G, c, d). 
We next quantified the colocalization of TM4SF5, EGFR, and integrin α5 in various 
combinations over whole-cell areas by using MOC analysis. MOC for the association between 
TM4SF5WT and EGFR (MOCTM4SF5-WT/EGFR) was approximately 0.7 without MβCD 
treatment, and it increased significantly (P < 0.005) after MβCD treatment. MOCTM4SF5-
Pal−/EGFR also nonsignificantly increased after MβCD treatment (P ≥ 0.05; Fig 3. 9A). Moreover, 
MOCTM4SF5-WT/integrin α5 was approximately 0.5 without MβCD treatment, and it decreased 
significantly (P < 0.05) after MβCD treatment (Fig 3. 4H), which recapitulated our immunoblot 
observations (Fig 3. 1F, lanes 2 and 6). However, MOCTM4SF5-Pal−/integrin α5 was not altered 
by MβCD treatment (P > 0.05; Fig 3. 4H). MOCEGFR/integrin α5 was higher in SNU761-Mock 
cells than in SNU761-TM4SF5WT cells, and upon MβCD treatment, MOCEGFR/integrin α5 
significantly increased in SNU761-Mock cells and insignificantly decreased in TM4SF5WT cells 
(Fig 3. 4I). In TM4SF5Pal− cells, MOCEGFR/integrin α5 was unaltered by MβCD treatment (Fig 
3. 4I). Taken together, these data demonstrated that the interaction between TM4SF5 and EGFR 
was stronger than that between TM4SF5 and integrin α5. Moreover, these data suggest that 
TM4SF5WT has differential binding affinities for EGFR and integrin α5, depending on its 
palmitoylation state and cellular cholesterol levels. Furthermore, upon depletion of cholesterol, 
TM4SF5WT and EGFR colocalized at internal T5ERMs, where caveolin-1 and cholesterol may 
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be reduced or absent, and integrin α5 remained alone at membrane boundaries. In comparison, 
TM4SF5Pal- seemed to be less dynamically coordinated with its interacting partners. 
TM4SF5 complex is dynamically dispersed over a migratory cell.  
Next, we explored how TM4SF5 coordinated protein interactions during migration. First, we 
analyzed protein interactions in cells migrating toward a wounded area by dividing migratory 
cells into front and rear regions via a line parallel to the direction of the wound and quantifying 
PLA signals in each region (Fig 3. 6A). The interaction between TM4SF5 and integrin α5 was 
slightly higher in the front than in the rear regions (P < 0.05; Fig 3. 6B), whereas the interaction 
between TM4SF5 and EGFR was much higher in the front than in the rear regions (P < 0.0001; 
Fig 3. 6B). 
We then directly investigated the interaction dynamics among protein molecules in live cells 
by using dual-color FCCS. FCCS is a technique that uses 2 spectrally distinct fluorophores to 
measure the kinetics of molecular interactions at a specific position in a single live cell [88] [90]. 
To analyze the spatial interactions of TM4SF5 and either EGFR or integrin α5, FCCS was 
performed in SNU761 cells that coexpressed TM4SF5-mCherry and EGFR-GFP or integrin α5-
GFP. If the 2 proteins form a complex, we should detect the codiffusion of mCherry and GFP as 
they transit the detection volume. The strength of the interaction is represented by the relative 
cross-correlation amplitude {[Gc(0)-1]/[Gr(0)-1]; see Materials and Methods}. FCCS 
measurements were positioned on the front or rear region of the plasma membrane in the cell 
bottom (Figs 2.6C–G). A significant interaction was detected between TM4SF5-mCherry and 
integrin α5-GFP at the plasma membrane compared with that between mCherry and the monomer 
GFP (Fig 3. 6D and Fig 3. 7), and averaged interactions in the front region were insignificantly 
higher than those in the rear region (Figs 3. 6C, D and G). In contrast, the interaction of TM4SF5-
mCherry with EGFR-GFP in the front region was significantly higher than that in the rear region 
(P < 0.05; Figs 3. 6E, F and G). Thus, TM4SF5 interacted with integrin α5 and EGFR on the 
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membrane of live cells, and PLA and FCCS analyses suggest that the complexes between 
TM4SF5 and EGFR preferentially localize to the front regions of migrating cells. 
We then directly investigated the interaction dynamics among protein molecules in live cells 
by using dual-color FCCS. FCCS is a technique that uses 2 spectrally distinct fluorophores to 
measure the kinetics of molecular interactions at a specific position in a single live cell [88] [90]. 
To analyze the spatial interactions of TM4SF5 and either EGFR or integrin α5, FCCS was 
performed in SNU761 cells that coexpressed TM4SF5-mCherry and EGFR-GFP or integrin α5-
GFP. If the 2 proteins form a complex, we should detect the codiffusion of mCherry and GFP as 
they transit the detection volume. The strength of the interaction is represented by the relative 
cross-correlation amplitude {[Gc(0)-1]/[Gr(0)-1]; see Materials and Methods}. FCCS 
measurements were positioned on the front or rear region of the plasma membrane in the cell 
bottom (Figs 3. 6C–G). A significant interaction was detected between TM4SF5-mCherry and 
integrin α5-GFP at the plasma membrane compared with that between mCherry and the monomer 
GFP (Fig 3. 6D and Fig 3. 7), and averaged interactions in the front region were insignificantly 
higher than those in the rear region (Figs 3. 6C, D and G). In contrast, the interaction of TM4SF5-
mCherry with EGFR-GFP in the front region was significantly higher than that in the rear region 
(P < 0.05; Figs 7E- G). Thus, TM4SF5 interacted with integrin α5 and EGFR on the membrane 
of live cells, and PLA and FCCS analyses suggest that the complexes between TM4SF5 and 
EGFR preferentially localize to the front regions of migrating cells. 
 Furthermore, MβCD treatment did not significantly alter the interaction of TM4SF5-
mCherry with EGFR-GFP, which differs from the significantly increased MOCTM4SF5-
WT/EGFR that we observed after MβCD treatment using confocal microscopy (Figs 3. 4F and 3. 
4H), but it did largely decrease the interaction of TM4SF5-mCherry with integrin α5-GFP (Fig 3. 
8). Detection volumes assessed by FCCS were located at membrane edges, where the interaction 
between TM4SF5 and EGFR could be reduced, although insignificantly, by their translocation 
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from the boundary to internal T5ERMs upon MβCD treatment. Therefore, discrepancies in 
measurements of TM4SF5 and EGFR interaction after MβCD treatment between FCCS and 
confocal immunofluorescence may be a result of differences in the subcellular locations of their 
detection volumes. 
To observe dynamic interactions and translocation of proteins at a higher resolution, we next 
obtained images by using Airyscan higher-resolution microscopy. Consistently, TM4SF5-
mCherry and EGFR-GFP were abundant at membrane boundaries before MβCD treatment, but 
were dynamically reduced at the boundaries and enriched at internal T5ERMs after MβCD 
treatment (Fig 3. 9A). Moreover, TM4SF5-mCherry and integrin α5-GFP were enriched at the 
boundaries before MβCD treatment, but only integrin α5-GFP was present at the boundaries after 
MβCD treatment (Fig 3. 9B). 
TM4SF5Pal--mCherry and EGFR-GFP were colocalized distally from the membrane 
boundaries, whereas TM4SF5Pal- -mCherry and integrin α5 were less colocalized (Fig 3. 9C). 
TM4SF5 PTMs promote migration directionality and velocity. 
We next examined the biologic significance of TM4SF5 PTMs in cellular migration. On the 
basis of tracking analyses during cell migration, TM4SF5WT and TM4SF5ICL-Pal− cells showed 
a tendency to migrate more persistently than did mock-transfected, TM4SF5ICL-Pal−, 
TM4SF5Pal- , or TM4SF5NQNA cells (Fig 3. 10A). Velocities of TM4SF5WT and TM4SF5ICL-
Pal− cells were significantly greater than those of mock-transfected, TM4SF5Pal-, or 
TM4SF5NQNA cells (P < 0.05; Fig 3. 10B, C). TM4SF5WT and TM4SF5ICL-Pal− cells also 
had higher indices of directionality than did mock-transfected, TM4SF5Pal−, or TM4SF5NQNA 
cells (Fig 3. 10D). Thus, these data indicate that palmitoylation and N-glycosylation of TM4SF5 
are important for migration velocity and directionality. 
PTM-dependent TM4SF5 complex formation promotes invasive dissemination from 
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spheroids in 3D gels. 
To determine whether TM4SF5 PTMs are involved in invasive migration in 3D collagen I 
gels, we prepared mock-vector, TM4SF5WT, or TM4SF5-mutant cell spheroids (70–100 μm) by 
using the hanging-drop technique, then we embedded the spheroids into 3D gels with normal 
serum–containing medium before imaging them by using time-lapse microscopy. Phenotype 
variations among spheroids were categorized by using the levels described in Fig 3. 10. 
TM4SF5WT cells showed dynamic, invasive outgrowth and dramatic dissemination from the 
spheroids (level 3), mock-vector and TM4SF5NQNA cells showed less active outgrowth and no 
dissemination (level 2), and TM4SF5Pal- cells showed no outgrowth or dissemination (level 1; Fig 
3. 10E). TM4SF5NQNA cells likely did not disseminate, because TM4SF5NQNA did not localize 
to plasma membranes (Fig 3. 3E). Taken together, these data suggest that TM4SF5 PTMs are 
required for cell invasion. Furthermore, TM4SF5WT-mediated invasive dissemination was 
abolished by MβCD treatment in a dose-dependent manner, which demonstrated that this invasive 
effect of TM4SF5 was cholesterol dependent (Figs 3. 10F and G). 
Next, we tested the dependency of the TM4SF5WT-dependent disseminative phenotype on 
EGFR and integrin α5 activity. TM4SF5WT spheroids showed mostly level 3 phenotypes; 
however, upon treatment with a specific EGFR inhibitor, gefitinib, there was a decrease in level 
3 and an increase in level 2 and 1 TM4SF5WT spheroids (Fig 3. 10H and Fig 3. 11A). Similarly, 
when integrin α5–mediated signaling activation was blocked by using an anti-human integrin α5 
mAb or the FAK inhibitor PF-271 (a specific FAK inhibitor PF-562271) [30], TM4SF5WT 
spheroids showed a decrease in level 3 and 2 spheroids and an increase in level 1 spheroids (Fig 
3. 10I and Fig 3. 11B, C). These data therefore suggest that TM4SF5WT promotes cell 
invasiveness, and thus, metastatic potential, via its PTM-dependent crosstalk with EGFR and 
integrin α5. 
PTM-dependent TM4SF5 complex formation promotes invasive dissemination from 
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spheroids in 3D gels. 
We next investigated how TM4SF5 modulated the signaling activities of EGFR and integrin 
α5. First, we analyzed the phosphorylation of FAK and EGFR in HEK293T cells that were 
transiently transfected with mock vector, TM4SF5WT, or different TM4SF5 mutants with 
cysteine to alanine substitutions. TM4SF5WT and TM4SF5ICL-Pal−, but not TM4SF5Pal-, 
promoted FAK activity after cell adhesion, as indicated by increased levels of pY577FAK, 
whereas TM4SF5WT, TM4SF5Pal-, and TM4SF5ICL-Pal− increased pY1173EGFR levels (Fig 3. 
12A). These data suggested that TM4SF5 palmitoylation is required for TM4SF5-mediated FAK 
activation but is dispensable for TM4SF5-mediated EGFR activity. Accordingly, the increased 
binding of TM4SF5Pal- with EGFR, compared with integrin α5 (Fig 3. 1F), could explain this 
differential signaling crosstalk. 
To assess the signaling downstream of integrin α5-FN–mediated adhesion and/or EGF 
binding to EGFR, cells were suspended or reseeded onto FN-precoated dishes for 90 min with or 
without a short EGF treatment. As an indication of integrin activation upon cell adhesion to ECM 
substrates, phosphorylation of FAK and paxillin were increased in mock vector-transfected cells 
by FN-adhesion and they were further enhanced in TM4SF5WT and TM4SF5Pal- cells but not 
TM4SF5NQNA cells (Fig 3. 12B). Upon EGF treatment, FN adhesion–dependent FAK and 
paxillin phosphorylation were maintained in TM4SF5WT cells but were reduced in TM4SF5Pal- 
cells compared with those without EGF treatment (Fig 3. 12B). These data suggest that 
TM4SF5WT coordinates adhesion- and EGF-mediated signaling pathways, whereas TM4SF5Pal- 
fails to coordinate adhesion-mediated FAK activity upon EGF treatment, presumably because 
there is no synergy between adhesion- and EGFR-mediated signaling activities in TM4SF5Pal- 
cells. 
Finally, immunostaining showed that TM4SF5, EGFR, and integrin α5 were colocalized in 
the disseminative cells from TM4SF5WT spheroids in 3D gels, but not from TM4SF5Pal- 
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spheroids (Fig 3. 12C). However, MβCD treatment of TM4SF5WT spheroids did not cause 
dissemination, leaving integrin α5 alone at the membrane edges (Fig 3. 12C), recapitulating the 









Figure 3. 1. Continued 
 
Figure 3. 1. Co-localization of TM4SF5 with EGFR and integrin a5 at the leading edges of 
migratory cells. (A) Whole cell lysates from SNU761 cells were precipitated using streptavidin-
agarose, before immunoblotting. See also Table 3. 1. (B) Confluent cells in 10% FBS-containing 
media were wounded and incubated for 24 h before immunostaining. Dotted areas are enlarged 
to show details. (C) Cells were wounded and washed with culture media. One day later, the 
wounded regions were immunostained for anti-Flag-Alexa 488, and then the PLA assay was 
performed for EGFR and active integrin a5. Yellow arrowheads depict overlap between the green 
Flag-Alexa 488 and red PLA signals. (D) SNU761 cells treated with vehicle or MbCD (10 mM) 
for 1 h were fractionated using the ProteoExtract® Subcellular Proteome Extraction Calbiochem® 
kit before immunoblotting. (E and F) SNU761 cells transiently transfected with Mock or 
TM4SF5 were harvested with lysis buffer including Brij58 (E) or Brij97 (F) detergent before 
precipitation using streptavidin-agarose and immunoblotting. (E, insert) RT-PCR was performed. 








Figure 3. 2. Posttranslational modifications of TM4SF5. (A)Cells expressing strep-tagged 
Mock, TM4SF5WT, orTM4SF5NQNA mutant were harvested for whole cell lysates and 
immunoprecipitated with Sreptavidin-agarose (Streptavidin), prior to blotting for Strep-tag, pTyr, 
orpSer/Thr antibodies. The big dark dot at the right side of phospho-Tyr blot is a nonspecific 
signal. (B) The amino acid sequences of the transmembrane 4 L six family members including 
TM4SF1, TM4SF4, TM4SF5, TM4SF18, and TM4SF20 were aligned for sequence conservations 
at different colored highlights; cytosolic cysteines proximal transmembrane domains were 
marked with red boxes. (C) SNU761 cells transfected with diverse constructs for the indicated 
TM4SF5forms were labeled with 3H-palmitate and harvested with 0.1% SDS-containing lysis 









Figure 3.3. PTMs of TM4SF5 affected the localization and interaction with EGFR and 
integrin α5. (A) The amino acid residues in red boxes depict cysteines that were mutated in the 
palmitoylation-deficient TM4SF5Pal-.See also Fig 3. 2. (B and C) Autoradiography for H+-
palmitate loading to TM4SF5. HEK293A cells transiently transfected with diverse constructs 
were labeled with [9,10-3H]palmitate for 2 h in L-15 medium with FBS before harvesting for 
whole cell lysates, precipitation using streptavidin-agarose, immunoblotting, and autoradiography 
(B), or before liquid scintillation analysis for counts per minute (CPM) (c). See also Fig 3. 2C. (D 
and E) Stable SNU761 cells infected by retrovirus for diverse constructs were processed for 
sucrose gradient (0 to 40%) fractions (0 to 11) before immunoblotting (D) or maintained overnight 
on FN-precoated coverslips in normal media for immunofluorescence using a confocal laser 
microscopy. (F) Cells infected with retrovirus for mock or diverseTM4SF5 forms were used for 



















Figure 3. 4. TM4SF5 localization and interaction with EGFR or integrin a5 upon cholesterol 
depletion. (A and B) Sucrose gradient fractionation using Triton X-100 or Brij97-containing lysis 
buffer was performed before immunoblotting (A). * depicts nonspecific bands. Band intensities 
were measured and graphed (B). (C) Sucrose gradient fractions of lipid raft-like (fractions 3, 4, 
and 5) or non-raft fractions (fractions 9, 10, and 11) prepared from SNU761-TM4SF5WT cells 
treated with vehicle or MbCD (10 mM) for 1 h were immunoblotted. * depicts nonspecific bands. 
(D and E) Cells cultured on FN-precoated coverslips under normal culture media were treated 
with MbCD (10 mM) for 1 h before staining using antibodies or phalloidin as indicated, and 
visualized using a confocal microscope. The images for TM4SF5-Flag were further analyzed to 
distinguish if the fluorescence was distal or proximal to the plasma membrane (though the cut 
purple lines) as shown in the fluorescence intensity histograms (D). See also Fig 3. 5. The white 
arrowheads depict co-localization of the three molecules, the red heads depict integrin a5 alone, 
and sky blue * depicts co-localization between TM4SF5 (blue) and EGFR (green). (Bottom panel) 
Two different regions of SNU761-TM4SF5WT cells treated with MbCD were enlarged for 
visualization of details. (F and G) Cells treated with vehicle (Control) or MbCD were 
immunostained for TM4SF5-Flag (blue), EGFR (green), and integrin a5 (red). The dotted areas 
(area a, b, c, and d) were enlarged to show details (G). (H and I) Co-localization between 
TM4SF5 and EGFR or integrin a5 (H) or between EGFR and integrin a5 (I) were calculated for 
MOC. Multiple random images from independent experiments were counted for the values. * 




Figure 3. 5. 
 
 
Figure 3. 5. Related Fig 3. 1D.TM4SF5WT was translocated to regions distal from plasma 
membranes after MβCD treatment (internal T5ERM), where lysozyme trackers were not 
overlapped as marked with a bracket.TM4SF5-GFP was transfected intoSNU761 cells for 48 
h, and then LysoTracker® Red DND-99 (Thermo Fisher) was treated to culture media for 30 min, 
before imaging (left). Then MβCD 4 mM was treated to the media for 1 h at 37°C, before another 
imaging (right). Note that the TM4SF5WTlocalization at the regions distal from the membrane 









Figure 3. 6. Dynamically coordinated interactions among TM4SF5, EGFR, and integrin a5. 
(A and B) Cells were seeded on FN-precoated coverslips overnight, wounded, washed twice with 
fresh media, and incubated for 24 h, before the PLA assay. The cutline between the front and rear 
regions of a migratory cell was applied so that it was perpendicular to the longest cellular length 
toward the free space. Yellow arrows indicate the migratory direction (A). The relative PLA signal 
fractions for the front or rear area were plotted for co-localization between TM4SF5 and integrin 
a5 or EGFR (B). (C to F) Representative fluorescence image of a SNU761 live cell co-expressing 
TM4SF5-mCherry and either integrin a5-GFP (C) or EGFR-GFP (E). Scale bar, 20 mm. The F 
and R boxes indicate the front and rear regions of the migratory cells, respectively. Enlarged 
images of the front and rear regions of the cell are also shown. Scale bar, 5 mm. The crosshair 
indicates the FCCS measurement position (C and E). Change over time of average fluorescence 
intensity (upper) of TM4SF5-mCherry (red) and integrin a5-GFP (green) or EGFR-GFP (green) 
and three corresponding fluorescence correlation functions (bottom) obtained from FCCS 
measurements of the positions shown in (C) or (E), respectively. Fluorescence intensity is 
indicated by count per second (cps) in kHz. Two FAF curves and one FCF curve (black) indicate 
a meaningful interaction (D and F). (G) Summary of the mean value of (Gc(0)-1)/(Gr(0)-1) 
representing the interaction between TM4SF5-mCherry and integrin a5-GFP (or EGFR-GFP) at 
the front and the rear region of the cell bottom. Negative control (dotted dash line) indicates the 
mean value of (Gc(0)-1)/(Gr(0)-1) = 0 obtained from cells co-expressing GFP and mCherry (See 
also Figs. S4 and S5). The data shown represent the mean value from at least three independent 




Figure 3. 7. 
 
Figure 3.7. Negative control of FCCS measurement. (A)Representative fluorescence image of 
a SNU761 live cell co-expressing mCherry and monomer GFP was shown. Scale bar, 20μm. The 
crosshairs indicated the measured position of FCCS. (B) Changes overtime in average 
fluorescence intensity(upper) of mCherry (red) and GFP(green), and three corresponding 
fluorescence correlation functions(bottom) obtained from FCCS measurement of the position in 
(A)were shown, respectively. Fluorescence intensity was indicated by count per second (cps) in 
kHz. No positive cross-correlation curve was detected. (C) Another FCCS result without photo 
bleach obtained from a lowly expressed cell was also shown for comparison. 
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Figure 3. 8. 
 
Figure 3.8. TM4SF5interaction with EGFR or integrin α5 at membranes of cell bottom upon 
MβCD treatment. Summary of the mean value of (Gc(0)-1)/(Gr(0)-1) representing the 
interaction between TM4SF5-mCherry and integrin α5-GFP (or EGFR-GFP) at the bottom 
membrane regions of SNU761 cells before (control) and after treatment of MβCD (4 mM) for 30 
min. It is noted that FCCS measurement was performed at the edge regions of the cell membrane. 
The data shown represent the mean ± standard deviation from at least three independent 
experiments (6 cells, n=35). Double asterisks depict significant statistics at different p-value as 
indicated. NS depicts non-significant with p-value > 0.05. 
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Figure 3. 9. Continued 
 
Figure 3. 9. Dynamic association and translocation among TM4SF5, EGFR, and integrin a5 
depending on MbCD treatment. SNU761 cells transiently transfected with human TM4SF5WT-
mCherry and EGFR-GFP (A) or TM4SF5WT-mCherry and integrin a5-GFP (B) plasmids for 48 
h were imaged by Airyscan higher-resolution microscopy. After regular imaging (before MbCD 
treatment), MbCD (10 mM) was added to culture media and 10 min later the same cells were 
imaged again (after MbCD treatment). (A) Yellow stains for co-staining between TM4SF5-
mCherry and EGFR-GFP marked with a white arrowhead indicates dynamic movement from 
internal area toward cellular boundary (as translocating away from ‘a’ land mark) and reached to 
the edges (dotted boxes) before MbCD treatment, whereas the internal yellow spot intensity 
decreased at the membrane edges (dotted boxes) and steady at internal regions (white arrowhead 
around ‘b’) after MbCD treatment. (B) Yellow spots depict co-staining between TM4SF5-
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mCherry and integrin a5-GFP and their co-staining was clearly maintained along the membrane 
edges and internal regions before MbCD treatment (dotted box, right and bottom panels), whereas 
they switched to green after MbCD treatment (dotted box, bottom). (C) TM4SF5Pal--mCherry and 
EGFR-GFP (top panels) or TM4SF5Pal--mCherry and integrin a5-GFP (bottom panels) plasmids 
for 48 h were imaged by Airyscan higher-resolution microscopy. Note that the cell morphologies 

















Figure 3.10. PTMs of TM4SF5 modulated migration velocity and directionality in 2D cell 
systems and cellular dissemination from spheroids embedded in 3D collagen I gels. (A to D) 
SNU449 cells infected with retrovirus for mock and diverse TM4SF5-HAII forms were seeded 
on FN-precoated slide-chambers in normal culture media. Ten cells per condition were tracked 
for 15 h (A). Migration velocity (mm/sec) of each tracked-cell was plotted against time from 0 to 
6 h (B) to view the trends of earlier velocity changes, leading to scatter dot plots to compare the 
mean velocities (C) or directionality (D) between TM4SF5 forms. The directionality was defined 
as the ‘direct distance from the start to the end point divided by total track distance’. * and ** 
depict significance at the p values indicated. (E to I) SNU449 cells stably infected with retrovirus 
for control vector or diverse TM4SF5-HAII forms were processed for spheroid formation and 
embedded in 3D collagen I gels before time-lapse imaging for 20 h (20:00) in the absence (E) or 
presence of vehicle or MbCD (4 mM, f and g), gefitinib (1 mM, h), PF271 (1 mM), or anti-human 
integrin a5 mAb (20 mg/ml, P1D6 clone, I). Cells were infected by LifeAct-GFP adenovirus 
before hanging-drop system. Arrowheads show single cells disseminating from TM4SF5WT 
spheroids. The red numbers to the right depict the numbers for the indicated phenotypes over the 
total number. Scale bars depict 50 mm. Level 1 depicts no-dissemination, level 2 depicts no 
dissemination but does depict the formation of outbound processes, and level 3 depicts 
dissemination. Each level was counted and graphed (G to I). See also additional figure 3. 11. The 




Figure 3. 11. 
 
Figure 3. 11. Related to Figs. 5H and I. Blocking of EGFR- or integrin-fibronectin adhesion 
mediated signaling decreased the TM4SF5WT-mediated dissemination from spheroids 
in3D collagen I gels. (A) Spheroids of the cells were embedded in the presence of vehicle 
(Control) or gefitinib (1 μM, a specific EGFR inhibitor), and then live imagings were performed 
for 20 h. Scale bars depict 50 μm. (B and C) Spheroids of the cells (SNU449-Mock; B, SNU449-
TM4SF5WT; c) were embedded in the presence of normal IgG, anti-human integrinα5 mAb (20 
μg/ml, functional neutralizing P1D6 clone), or PF271 (1 μM, a specific FAK inhibitor), and then 
live imagings were performed for 20 h. Scale bars depict 50 μm. Red numbers in right side depict 
the case numbers for the indicated phenotypes over total cases. 
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Figure 3.12. PTMs of TM4SF5 affected signaling activities via coordination with EGFR and 
integrin a5. (A) Hek293T cells expressing different constructs were harvested and processed for 
standard Western blots. (B) SNU449 cells (as explained in Fig 3. 4) were maintained in suspension 
without serum (S) or reseeded onto FN-precoated culture dishes (1.5 h) without or with EGF (100 
ng/ml for the final 10 min) treatment (FN + EGF), before harvesting and immunoblotting. (C) 
SNU449 spheroids embedded in 3D collagen gels without or with MbCD treatment were 
processed for immunostaining for TM4SF5 (red), EGFR (blue), and integrin a5 (green). White 
dotted boxes indicates the cell groups that are disseminated (A) or non-disseminated (B and C). 
(D) Working model for protein complexes between TM4SF5, EGFR, and integrin a5 to direct 
cellular migration. Normally, cells form T5ERM proximal to or distal from the leading edges of 
migratory cells, and migration velocity and directionality is promoted (top, normal condition). 
When the T5ERM is disrupted by either depletion of cellular cholesterol, N-glycosylation-
deficiency, or palmitoylation-deficiency in TM4SF5, T5ERM formation could be abolished, 




Table 3. 1. The list of TM4SF5 binding membrane proteins. SNU761 cells were ectopically 
transfected with control or Strep-tag-conjugated TM4SF5WT plasmid for 48 h, and then extracted 
using a lysis buffer with mild detergent Brij58. Lysates were immunoprecipitated using 
streptavidin-agarose. After in-gel trypsin digestion of proteins, peptides were analyzed in LC-
MS/MS. The amino acid sequence can be deduced after searches in the NCBI data using the 
program SEQUEST. Data was organized by Human IPI database (Ver. 3.82) and analyzed by 
SCAFFOLD 3 analysis. The experiments were twice tried. 
No Protein Molecular Weight 



















1 Isoform b-1A of Integrin b1 88 kDa 22 23 - - 
2 Isoform 1 of Integrin a3 117 kDa 16 16 - - 
3 Isoform 8 of CD44 antigen 74 kDa 11 17 - - 
4 Integrin a2 129 kDa 11 11 - - 
5 Isoform 1 of Integrin aV 116 kDa 10 10 - - 
6 Integrin a5 115 kDa 8 9 - - 
7 Cadherin-2 100 kDa 7 9 - - 
8 Isoform 1 of a-catenin-1 100 kDa 9 7 - - 
9 Isoform 1 of b-Catenin-1 85 kDa 2 5 - - 
10 Isoform Alpha-6X1X2B of Integrin a6 127 kDa 5 6 - - 
11 Isoform a-7X1X2B of Integrin 
a7 
129 kDa 1 2 - - 
12 Integrin a1 131 kDa 1 2 - - 
13 Isoform 1 of Epidermal growth factor receptor 134 kDa 3 2 - - 
14 Isoform 1 of Basic fibroblast growth factor receptor 1 92 kDa 1 - - - 







Protein networks on the plasma membrane have been shown to play dynamic roles in 
regulating cellular functions; however, the roles of intra-TERM dynamic protein associations and 
translocations during cell migration remain unexplored. In this study, we demonstrated that 
TM4SF5 interacted with EGFR and integrin α5 at the leading membrane edges of migratory cells 
to steer migration. TM4SF5-EGFR interactions were strongly enriched in the front region of 
migratory cells, presumably at T5ERMs, whereas TM4SF5-integrin α5 interactions were only 
slightly enriched in the front region of cells compared with that observed in the rear region. Upon 
MβCD treatment, integrin α5 remained alone at the leading edges, whereas TM4SF5WT and 
EGFR translocated to internal T5ERMs, dependent on TM4SF5WT PTMs. Furthermore, 
TM4SF5 cooperated with EGFR and integrin α5 for effective 2D cell migration or 3D gel 
dissemination and engaged in crosstalk with EGFR and integrin α5 for differential synergistic 
signal transduction. These functions were also dependent on TM4SF5WT PTMs. Taken together, 
these data suggest that the differential association and localization of TM4SF5 with EGFR and/or 
integrin α5 allows for fine-tuning of signaling activities that regulate dynamic cellular and 
biochemical processes in the leading edge of migratory cells. Furthermore, this study revealed 
dynamic aspects of coordinated protein associations within T5ERMs, which occur proximal to or 
distal from the leading membrane edges, depending on cellular cholesterol levels and TM4SF5 
PTM state (Fig 3. 12D). 
On the plasma membrane, various membrane protein–containing microdomains are 
organized to form membranous compartments via massive protein-protein interactions [91]. In 
addition to lipid rafts or caveolae, which are enriched for cholesterol and glycosyl-
phosphatidylinositol–linked proteins that transduce specific signals [92], there are TERMs, which 
are enriched for tetraspanins, such as TM4SFs, that form protein complexes with growth factor 
receptors and integrins [11]. There are common and unique aspects between lipid rafts and 
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TERMs [2]. Here, we showed that T5ERMs may be distinct from lipid rafts, because sucrose-
gradient fractionation, using Brij97 or following MβCD treatment, separated TM4SF5WT from 
caveolin-1 fractions. 
Protein-protein interactions of TM4SFs involve PTMs, such as N-glycosylation and 
palmitoylation. Previous studies have shown that N-glycosylation–deficient TM4SF5NQNA 
mutant no longer binds to integrin α2 [93] or CD44 [94], and in this study, we showed that it 
failed to bind to integrin α5 and EGFR, presumably because TM4SF5NQNA was not trafficked 
to the membrane surface and/or no glycosylated moiety was available for interactions. As with 
CD151 [87], TM4SF5 is also palmitoylated on cysteine residues, and mutation of all 9 cytosolic 
cysteines to alanines resulted in loss of >90% of H3+ palmitate loading. However, the TM4SF5Pal- 
or TM4SF5NQNA mutants exhibited altered migration velocity and directionality in 2D 
conditions as well as reduced invasive dissemination in 3D gel conditions compared with 
TM4SF5WT cells. 
Therefore, coordinated protein-protein interactions of TM4SF5 and EGFR with or without 
integrin α5 at boundary T5ERMs or internal T5ERMs during directional cell migration, 
respectively, were modulated by TM4SF5 PTMs and MβCD treatment. Moreover, such 
modulations of these coordinated interactions resulted in altered signaling activities that 
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TM4SF5-Enriched Microdomain을 통한 세포외기질 
환경과 아세틸화된 microtubule의 역동적 소통에 의한 
세포 이동 조절에 관한 연구 
 
김 혜 진 
 
막 단백질들은 세포 외부의 자극과 세포 내부의 신호전달을 
감지하여 세포가 이동 할 때 속도와 방향성을 결정하게 된다. 세포의 막에는 
lipid rafts 나 tetraspanin-enriched microdomain과 같은 특징적인 구역이 
존재하게 되는데, 이 안에서 일어나는 receptor들의 신호전달에 따라 
세포의 이동이 조절되게 된다. 본 연구에서는 막 단백질인 Transmembrane 
4 L six family member 5 (TM4SF5)가 세포 외 기질 (extracellular 
matrix(ECM)), cholesterol depletion 조건에 따라, 그리고 세포 
내부에서는 microtubule의 상태 변화와 TM5SF5-enriched 
microdomains(T5ERMs)에서 결합하고 있는 단백질이 조절됨에 따라서 
세포의 이동을 어떻게 조절하는지 확인 해 보았다.  
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먼저, TM4SF5가 endosome과 plasma membrane 사이에서 
위치하면서 세포의 이동을 조절하게 되는데, 이 때에 어떻게 trafficking이 
조절되는지에 대한 것은 연구가 되어 있지 않았다. TM4SF5를 과 발현 
시켜서 살아있는 상태에서 현미경으로 확인 한 결과 세포의 leading edge에 
TM4SF5가 많이 위치하고 있으며 이것이 세포의 지속적인 이동으로 
나타나는 것을 확인 하였다. 그리고 TM4SF5를 형광으로 표지 하여 
vesicle을 관찰 한 결과 vesicle의 이동 양상이 세포 부착 면에 코팅 된 
ECM이 fibronectin 일 때 속도가 빠르고 직선운동을 하는 것을 관찰할 수 
있었으며, 이 현상이 세포 주변의 ECM에 의해 영향을 받는 것을 확인 할 
수 있었다. 그리고 fibronectin에 부착된 세포에 synaptotagmin-like 
protein lacking C2 domains B (SLAC2B)가 감소하면 histone deacetylase 
6 (HDAC6)의 활성이 감소하는 것을 확인 하였고 이로 인해 tubulin의 
아세틸화가 증가하게 된다. 증가된 tubulin의 아세틸화는 TM4SF5 
vesicle의 이동이 빠르고 다이내믹하게 일어나게 하며 결국 세포의 이동 
속도를 증가시키게 되는 것을 확인 하였다. 요약하면 SLAC2B가 HDAC6와 
결합하여 HDAC6의 활성을 감소시키고, 이로 인해 tubulin의 acetylation이 
증가하게 되며 TM4SF5 vesicle이 세포의 leading membrane으로 
trafficking되게 하여 세포의 이동을 증가시킨다는 것을 확인 하였다. 
다음으로, TM4SF5가 세포막에서 T5ERMs을 형성하여 세포의 이동
을 조절하게 되는데 이 때에 epidermal growth factor receptor (EGFR)과 
integrin α5가 결합하고 있는 것을 proteomic analysis를 통해서 확인 하
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였다. 그리고 live fluorescence-correlation spectroscopy (FCCS)를 통해 
분자간의 물리적 결합이 일어나는 것을 확인 하였고, higher-resolution 
microscopy를 통하여 세포막의 leading edge에서 함께 존재하고 있는 것을 
확인 하였다. 또한 TM4SF5와 EGFR의 결합은 세포가 나아가는 앞쪽에서 
두드러지게 일어나고 integrin α5는 세포의 전면적으로 일어나는 것을 확인 
할 수 있었다. 또한 cholesterol depletion과 TM4SF5의 post translational 
modification을 일어나지 못하게 한 palmitoylation mutant, glycosylation 
mutant에서 TM4SF5와 EGFR, integrin α5의 결합 정도와 위치가 변화할 
뿐 아니라 세포의 이동 속도와 이동의 방향성을 조절한다는 것을 2차원뿐 
아니라 3차원 spheroid 배양 환경에서도 확인 할 수 있었다. 종합적으로 
endosome의 TM4SF5가 세포가 부착하고 있는 fibronectin의 신호를 받아
서 acetylation이 일어난 tubulin을 따라 세포막으로 trafficking되고 EGFR, 
integrin α5와 같은 receptor들을 만나 세포막의 leading edge에서 
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